{
    "testId": 396301560,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 101,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 4,
    "questionModeName": "CUSTOM",
    "testName": "",
    "totalQuestionCorrect": 15,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 0,
    "incorrectToIncorrect": 1,
    "timeInSeconds": 673,
    "averageTimeSpentInSeconds": 158,
    "otherAverageTimeSpentInSeconds": 65,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 30,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "4",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 22760,
            "questionIndex": 106813,
            "questionText": "<p>A 36-year-old woman, gravida 1 para 0, comes to the office for confirmation of pregnancy.&nbsp; She has had several years of infertility and recently underwent fertility treatment with ovulation induction.&nbsp; A transvaginal ultrasound reveals 3 fetal poles, each measuring 7 weeks gestation with normal fetal heart rates.&nbsp; The patient is concerned about carrying a triplet pregnancy and asks about the risks to her and each of the fetuses&#39; health with this pregnancy.&nbsp; The patient is counseled about her increased risk of preeclampsia with severe features and the increased risk of preterm delivery and prematurity in the fetuses.&nbsp; The physician discusses management options, including continuing the multifetal gestation pregnancy versus pregnancy reduction versus selective termination, with the patient.&nbsp; After discussion of the options, a decision is made to perform a multifetal pregnancy reduction to a singleton pregnancy.&nbsp; Which of the following is the ethical principle behind this decision?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t84498\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Risks of multiple gestation pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Maternal<br />complications</strong></p></td><td><ul><li>Hyperemesis gravidarum</li><li>Iron deficiency anemia</li><li>Preeclampsia, eclampsia</li><li>Gestational diabetes mellitus</li><li>Cesarean delivery</li><li>Postpartum hemorrhage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Fetal<br />complications</strong></p></td><td><ul><li>Preterm delivery</li><li>Fetal growth restriction</li><li>Congenital anomalies</li></ul></td></tr></tbody></table></div><p><strong>Beneficence</strong> is the physician&#39;s obligation to <strong>act in the patient&#39;s best medical interests</strong>.&nbsp; The primary patient during pregnancy is the mother.&nbsp; Therefore, when maternal and fetal interests conflict (which commonly occurs in pregnancy), medical decision-making is often based on <strong>prioritizing maternal health</strong> (ie, maternal beneficence) over fetal interests.</p><p>This patient has a triplet pregnancy.&nbsp; <strong>Multiple gestation pregnancies</strong> (eg, twin, triplet) have <strong>high maternal morbidity</strong>, including increased risk for preeclampsia, cesarean delivery, and postpartum hemorrhage.&nbsp; Fetal complications (eg, growth restriction, preterm delivery) are also more common.&nbsp; After considering these risks, patients may choose to <strong>continue multifetal pregnancy or undergo pregnancy reduction</strong>, a procedure that induces asystole in &#8805;1 fetuses to create a lesser order gestation (eg, singleton pregnancy).&nbsp; Multifetal pregnancy reduction chooses the reduced fetus(es) randomly (in contrast, selective termination selects intentionally by fetal trait [eg, sex, chromosomal abnormality]).</p><p>In this scenario, the decision to perform a multifetal pregnancy reduction is primarily based on <strong>maternal beneficence</strong> because reduction to a singleton pregnancy would decrease this patient&#39;s risks for preeclampsia, postpartum hemorrhage, and cesarean delivery.&nbsp; Any fetal benefits gained, such as improved odds for term delivery of the remaining fetus, are secondary to the primary principle of maternal beneficence.</p><p><strong>(Choices A and D)</strong>&nbsp; Justice is the ethical principle of fair and equitable treatment, such as equal distribution of scarce medical resources and avoidance of discrimination.&nbsp; In this scenario, the basis for pregnancy reduction is maternal medical benefit rather than matters of maternal or fetal justice.</p><p><strong>(Choices B and E)</strong>&nbsp; Beneficence forms the foundation for many other ethical principles (eg, nonmaleficence, justice).&nbsp; Nonmaleficence differs from beneficence in that beneficence requires the addition of benefits (a positive requirement) rather than avoidance of harm through a nonaction (a negative requirement).&nbsp; In this scenario, upholding fetal or maternal nonmaleficence would involve expectant management (ie, not performing the procedure because the procedure itself carries risk).</p><p><strong>Educational objective:</strong><br>In a multiple gestation pregnancy (eg, triplet), pregnancy reduction to a lesser order gestation (eg, singleton) decreases maternal morbidity (eg, preeclampsia, postpartum hemorrhage).&nbsp; Therefore, multifetal pregnancy reduction is primarily performed for maternal beneficence (ie, acting in the best medical interests of the mother).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 6713,
            "topic": "Ethical principles in healthcare",
            "titleId": 6713,
            "title": "Ethical principles in healthcare",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Fetal justice",
                    "choiceNumber": 1,
                    "correctTaken": 113,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal nonmaleficence",
                    "choiceNumber": 2,
                    "correctTaken": 281,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal beneficence",
                    "choiceNumber": 3,
                    "correctTaken": 3386,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal justice",
                    "choiceNumber": 4,
                    "correctTaken": 184,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal nonmaleficence",
                    "choiceNumber": 5,
                    "correctTaken": 1269,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25017403",
                    "mediaDataId": 0,
                    "title": "Application of legal principles and medical ethics: multifetal pregnancy and fetal reduction.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25017403",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30641552",
                    "mediaDataId": 0,
                    "title": "American College of Physicians ethics manual: seventh edition.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30641552",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 5233,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 10881,
            "questionIndex": 12017,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 0, at 34 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; The patient has systemic lupus erythematosus with positive anti-Ro/SSA antibodies but has had no flares during this pregnancy.&nbsp; Her medications include hydroxychloroquine, low-dose aspirin, and a prenatal vitamin.&nbsp; Blood pressure is 130/88 mm Hg and pulse is 65/min.&nbsp; Fundal height is 33 cm.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Urine dipstick has trace protein.&nbsp; A nonstress test is performed for 10 minutes; results are shown in the <a href=\"4571\">exhibit</a>.&nbsp; Which of the following is the most likely etiology for this patient&#39;s fetal heart rate tracing?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t46410\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Nonstress test</strong></p></td></tr><tr><td><p><strong>Reactive</strong></p></td><td><ul><li>Baseline of 110-160/min</li><li>Moderate variability (6-25/min)</li><li>&ge;2 accelerations in 20 min, each peaking &ge;15/min above baseline&nbsp;&amp; lasting &ge;15 sec</li></ul></td></tr><tr><td><p><strong>Nonreactive</strong></p></td><td><ul><li>Does not meet criteria for reactivity</li></ul></td></tr></tbody></table></div><p>The <strong>nonstress test (NST)</strong> is commonly performed for pregnancies at risk for fetal hypoxemia, acidemia, and/or demise due to a maternal or fetal comorbidity (eg, systemic lupus erythematosus, fetal growth restriction) or for decreased fetal movement.&nbsp; During an NST, the heart rate of a well-oxygenated fetus rises with fetal movement (accelerations).&nbsp; A reactive NST (eg, normal baseline, moderate variability, &#8805;2 accelerations) has a high negative predictive value for fetal acidemia.</p><p>This <a href=\"4572\">patient&#39;s NST</a> is <strong>nonreactive</strong> because it has no accelerations.&nbsp; Nonreactive NSTs are concerning for fetal hypoxemia and acidemia; however, the <strong>most common cause</strong> of a nonreactive NST is a <strong>quiet fetal sleep cycle</strong> (which lasts &#8804;40 min).</p><p>A typical NST is 20 minutes, but a nonreactive NST is extended (eg, 40-120 min) to ensure that fetal activity outside of quiet sleep is captured.&nbsp; Due to a high false-positive rate, nonreactive NSTs are further evaluated with either a biophysical profile or contraction stress test before concluding that the fetus may be hypoxemic and needs intervention.</p><p><strong>(Choice A)</strong>&nbsp; Congenital fetal heart block is a complication of systemic lupus erythematosus or Sjogren syndrome in pregnancy, due to anti-Ro/SSA antibodies crossing the placenta.&nbsp; However, fetal heart block typically causes fetal bradycardia (&lt;110/min), not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Fetal head compression causes <a href=\"2411\">early decelerations</a>, shallow decreases in the fetal heart rate that occur with contractions.&nbsp; These benign decelerations are likely the result of a fetal autonomic response to the alterations in intracranial pressure caused by contractions.&nbsp; There are no decelerations or contractions on this patient&#39;s NST.</p><p><strong>(Choice C)</strong>&nbsp; Fetal heart rate accelerations require a mature sympathetic nervous system, which develops at 26-28 weeks gestation; therefore, extremely premature fetuses (&lt;28 weeks gestation) often do not demonstrate reactivity.&nbsp; This patient is at 34 weeks gestation.</p><p><strong>(Choice E)</strong>&nbsp; Uteroplacental insufficiency causes <a href=\"1820\">late decelerations</a>, which are shallow drops in the fetal heart rate of uniform depth and duration occurring after the onset of a contraction.</p><p><strong>Educational objective:</strong><br>Quiet fetal sleep is the most common cause of a nonreactive nonstress test (eg, no accelerations).&nbsp; Because a fetal sleep cycle can last as long as 40 minutes, a nonreactive nonstress test is extended (eg, 40-120 min) to ensure that fetal activity outside of sleep is captured.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23380,
            "topic": "Antepartum fetal testing",
            "titleId": 23380,
            "title": "Antepartum fetal testing",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Congenital fetal heart block",
                    "choiceNumber": 1,
                    "correctTaken": 2624,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal head compression",
                    "choiceNumber": 2,
                    "correctTaken": 278,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal prematurity",
                    "choiceNumber": 3,
                    "correctTaken": 480,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quiet fetal sleep cycle",
                    "choiceNumber": 4,
                    "correctTaken": 12399,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uteroplacental insufficiency",
                    "choiceNumber": 5,
                    "correctTaken": 1006,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "690",
                    "mediaDataId": 0,
                    "title": "Antepartum fetal testing",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18757143",
                    "mediaDataId": 0,
                    "title": "Heart rate features in fetal behavioural states.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18757143",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24614020",
                    "mediaDataId": 0,
                    "title": "Factors that increase reactivity during fetal nonstress testing.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24614020",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27140936",
                    "mediaDataId": 0,
                    "title": "What we have learned about intrapartum fetal monitoring trials in the MFMU Network.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27140936",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27751795",
                    "mediaDataId": 0,
                    "title": "The limits of electronic fetal heart rate monitoring in the prevention of neonatal metabolic acidemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27751795",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 249,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16788,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 43,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 4174,
            "questionIndex": 4174,
            "questionText": "<p>A newborn boy is evaluated immediately after birth in the delivery room.&nbsp; He was born to a 24-year-old primigravida via spontaneous vaginal delivery at 38 weeks gestation.&nbsp; The amniotic fluid was clear.&nbsp; Pregnancy was uncomplicated with routine prenatal care, including negative infectious serologies and normal anatomic ultrasound.&nbsp; The patient cried immediately after birth and is actively moving all 4 extremities.&nbsp; His body is pink, but the hands and feet are cyanotic.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"59259\" src=\"https://www.uworld.com/media/highresdefault/L89264.png\"  ></p><p>The first step in evaluation of a term newborn immediately after birth is the assessment of respirations and muscle tone.&nbsp; Crying or breathing without distress indicates lung expansion, and extremity flexion and movement indicate good muscle tone (poor tone can signify neurologic or metabolic derangements).&nbsp; In this case, the patient is <strong>breathing</strong> and <strong>crying</strong> with <strong>good tone</strong>, features which allow for <strong>routine care</strong> with <strong>no need for resuscitation</strong>.</p><p>Newborns who do not need resuscitation should be <strong>placed on the mother&#39;s chest</strong> for at least 1 hour of <strong>skin-to-skin contact</strong> for the following reasons:</p><ul><li>To <strong>provide warmth</strong>:&nbsp; Newborns have an underdeveloped thermoregulatory center and are at risk for hypothermia, and skin-to-skin contact prevents heat loss.&nbsp; Other warming methods include swaddling with warm blankets and placing the newborn under a radiant warmer.</li></ul><ul><li>To promote <strong>early initiation of breastfeeding</strong> if desired:&nbsp; While on the mother&#39;s chest, newborns will often explore through innate reflexes (eg, rooting) and self-attach to the breast.&nbsp; This practice has been shown to decrease risk for breastfeeding complications (eg, cracked nipples), hypoglycemia, and hyperbilirubinemia.</li></ul><p>Routine newborn care (eg, vitamin K injection, erythromycin ophthalmic ointment) is typically postponed for 1 hour to allow for skin-to-skin contact.&nbsp; The hepatitis B vaccine should be administered in the first 24 hours but should not delay skin-to-skin contact immediately after birth <strong>(Choice A)</strong>.</p><p><strong>(Choices B and E)</strong>&nbsp; Central cyanosis (eg, blue discoloration of mucous membranes, trunk) is due to inadequate oxygenation and may indicate a congenital heart defect or pulmonary disease.&nbsp; These newborns typically warrant resuscitative measures including supplemental oxygen and cardiac monitoring.&nbsp; In contrast, this newborn has cyanosis of the hands and feet (acrocyanosis or peripheral cyanosis), which is a normal finding in healthy newborns due to physiologic peripheral vasoconstriction.&nbsp; Resuscitation and monitoring are not needed for acrocyanosis.</p><p><strong>(Choice C)</strong>&nbsp; Oropharyngeal suctioning may be necessary for excessive airway secretions; however, endotracheal suctioning is not recommended in routine neonatal resuscitation due to the risk for vagal stimulation and subsequent apnea or bradycardia.&nbsp; This patient is crying with a patent airway.</p><p><strong>Educational objective:</strong><br>Healthy, term newborns who have good tone (eg, moving vigorously) and are breathing/crying should be placed on the mother&#39;s chest for 1 hour of skin-to-skin contact, which provides warmth and allows for early initiation of breastfeeding.&nbsp; Routine newborn care may be postponed during this time.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12234,
            "topic": "Neonatal evaluation",
            "titleId": 12234,
            "title": "Neonatal evaluation",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer hepatitis B vaccine",
                    "choiceNumber": 1,
                    "correctTaken": 832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Attach to a cardiac monitor",
                    "choiceNumber": 2,
                    "correctTaken": 945,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform endotracheal suctioning",
                    "choiceNumber": 3,
                    "correctTaken": 1671,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Place on the mother&#39;s chest",
                    "choiceNumber": 4,
                    "correctTaken": 13782,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide supplemental oxygen",
                    "choiceNumber": 5,
                    "correctTaken": 2524,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30026787",
                    "mediaDataId": 0,
                    "title": "The effect of mother and newborn early skin-to-skin contact on initiation of breastfeeding, newborn temperature and duration of third stage of labor.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30026787",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "33081528",
                    "mediaDataId": 0,
                    "title": "Part 5: neonatal resuscitation: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/33081528",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 158,
            "othersAvgTimeSpent": 38,
            "notes": null,
            "peopleTaken": 19754,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 3278,
            "questionIndex": 3278,
            "questionText": "<p>A 26-year-old woman, gravida 1 para 0, at 32 weeks gestation comes to the office to establish prenatal care after recently moving.&nbsp; She reports no complications in this pregnancy.&nbsp; Blood pressure is 110/60 mm Hg and pulse is 90/min.&nbsp; On examination, fundal height is 26 cm and fetal heart rate is 140/min.&nbsp; Ultrasound calculates the gestational age as 28 weeks based on the fetal biparietal diameter, abdominal circumference, and femur length.&nbsp; On review of records, the patient had very irregular menses prior to pregnancy, and at her first prenatal appointment, she thought she was 6 weeks gestation based on her last menses.&nbsp; However, ultrasound at that visit measured the fetus at 8 weeks gestation, which adjusted the estimated due date.&nbsp; Given the multiple discrepancies in gestational age, which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t80749\"><table class=\"table-default-style\" style=\"width:432px\"><tbody><tr><td colspan=\"3\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Ultrasonographic assessment of gestational age</strong></p></td></tr><tr><td><p align=\"center\"><strong>Ultrasound parameter</strong></p></td><td><p align=\"center\"><strong>Gestational age<br />(weeks)</strong></p></td><td><p align=\"center\"><strong>Accuracy<br />(days)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Gestational sac diameter</strong></p></td><td><p align=\"center\">4.5-6</p></td><td><p align=\"center\">&plusmn;5-7</p></td></tr><tr><td rowspan=\"2\"><p align=\"center\"><strong>Crown-rump length</strong></p></td><td><p align=\"center\">7-10</p></td><td><p align=\"center\">&plusmn;3</p></td></tr><tr><td><p align=\"center\">11-14</p></td><td><p align=\"center\">&plusmn;5</p></td></tr><tr><td rowspan=\"3\"><p align=\"center\"><strong>Biparietal diameter, head circumference, femur length</strong></p></td><td><p align=\"center\">14-20</p></td><td><p align=\"center\">&plusmn;7</p></td></tr><tr><td><p align=\"center\">21-30</p></td><td><p align=\"center\">&plusmn;14</p></td></tr><tr><td><p align=\"center\">&gt;30</p></td><td><p align=\"center\">&plusmn;21-28</p></td></tr></tbody></table></div><p>Pregnancy dating and estimated gestational age (EGA) are used for fetal monitoring and testing and help determine timing of fetal interventions (eg, corticosteroids) and delivery.</p><p>Pregnancy dating is often confirmed with a first-trimester ultrasound showing the <strong>fetal crown-rump length</strong> measurement, which is <strong>accurate</strong> within 3 days of the gestational age.&nbsp; First-trimester ultrasound is particularly important for <strong>estimating gestational age</strong> in patients with irregular menses, as in this patient, and can <strong>reestablish</strong> the <strong>estimated due date (Choice B)</strong>.&nbsp; Although ultrasounds are used throughout pregnancy, they can become <strong>less accurate</strong> as the <strong>pregnancy advances</strong> (&plusmn;3 weeks in the third trimester) due to biologic variation and environmental in utero factors (eg, gestational diabetes, uteroplacental insufficiency).&nbsp; Therefore, once established, EGA is not changed based on later ultrasound estimates <strong>(Choices C and E)</strong>.</p><p>This patient who is at 32 weeks gestation based on a first-trimester ultrasound is now measuring at 28 weeks gestation, which is greater than the expected ultrasound variance in this trimester (&plusmn;3 weeks).&nbsp; Because this pregnancy was dated by a first-trimester ultrasound, the discrepancy between current gestational age and previous ultrasound findings represents abnormal fetal growth, not an inaccurate EGA.&nbsp; Therefore, this patient requires <strong>additional work-up</strong> for <strong>fetal growth restriction</strong> (eg, chromosomal studies, infectious etiology [TORCH titers]) and management with serial growth ultrasounds, antenatal testing (eg, biophysical profile), and umbilical artery dopplers.</p><p><strong>(Choice A)</strong>&nbsp; After 20 weeks gestation, a <a href=\"1834\">fundal height measurement</a> is used to screen for abnormal fetal growth (eg, fetal growth restriction, macrosomia); however, it is not used for gestational age estimation because it can be confounded by a variety of factors (eg, fibroids, obesity).&nbsp; When the measurement differs from gestational age by &#8805;3 cm, an ultrasound is required for additional evaluation.</p><p><strong>Educational objective:</strong><br>Ultrasound dating with fetal crown-rump measurement in the first trimester is the most accurate way to determine estimated gestational age (EGA).&nbsp; EGA should not be changed based on measurement discrepancies on a second- or third-trimester ultrasound.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19194,
            "topic": "Prenatal Care",
            "titleId": 19194,
            "title": "Prenatal Care",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjust the patient&#39;s gestational age to reflect the fundal height measurement",
                    "choiceNumber": 1,
                    "correctTaken": 494,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjust the patient&#39;s gestational age to reflect the last menstrual period",
                    "choiceNumber": 2,
                    "correctTaken": 985,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjust the patient&#39;s gestational age to reflect the most current ultrasound findings",
                    "choiceNumber": 3,
                    "correctTaken": 4644,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Further evaluate for fetal growth restriction",
                    "choiceNumber": 4,
                    "correctTaken": 8992,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat the ultrasound in 2 weeks to confirm this visit&#39;s gestational age",
                    "choiceNumber": 5,
                    "correctTaken": 1674,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19155920",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 101: ultrasonography in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19155920",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 225,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16789,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 2804,
            "questionIndex": 2804,
            "questionText": "<p>A 32-year-old woman, gravida 1 para 0, at 26 weeks gestation comes to the office for prenatal evaluation.&nbsp; The patient reports increasing shortness of breath and fatigue since her last visit 4 weeks ago.&nbsp; She now has to rest after several minutes of doing household chores or walking at an even pace on level ground.&nbsp; The patient reports no nausea or vomiting but states she is not drinking fluids as recommended.&nbsp; Medical history includes chronic hypertension, but the patient has not required antihypertensive therapy during the pregnancy.&nbsp; She takes daily prenatal vitamins containing iron.&nbsp; BMI is 34 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Blood pressure is 138/82 mm Hg and pulse is 90/min.&nbsp; Fundal height is 26 cm.&nbsp; Fetal heart tones are normal.&nbsp; Cardiac examination is notable for a 2/6 systolic murmur.&nbsp; The lungs are clear to auscultation bilaterally.&nbsp; There is 2+ pitting edema in both ankles.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Complete blood count</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11 g/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Sodium</td><td style=\"vertical-align:middle;\">134 mEq/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Potassium</td><td style=\"vertical-align:middle;\">3.6 mEq/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Chloride</td><td style=\"vertical-align:middle;\">102 mEq/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Bicarbonate</td><td style=\"vertical-align:middle;\">20 mEq/L</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">4 mg/dL</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">Creatinine</td><td style=\"vertical-align:middle;\">0.6 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Arterial blood gases</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">pH</td><td style=\"vertical-align:middle;\">7.46</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">PaO<font size=\"2\"><sub>2</sub></font></td><td style=\"vertical-align:middle;\">105 mm Hg</td></tr><tr><td style=\"vertical-align:middle; padding-left:2em;\">PaCO<font size=\"2\"><sub>2</sub></font></td><td style=\"vertical-align:middle;\">29 mm Hg</td></tr></tbody></table><p>Which of the following is the most appropriate next step in management of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t60024\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Physiologic changes of pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Cardiovascular</strong></p></td><td><ul><li>&uarr; Blood volume (plasma &gt; RBC mass)</li><li>&darr; Systemic vascular resistance</li><li>&uarr; Heart rate &amp; cardiac output</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pulmonary</strong></p></td><td><ul><li>&uarr; Central respiratory drive (hyperventilation)</li><li>&darr; PaCO<sub>2</sub> (respiratory alkalosis), &uarr; PaO<sub>2</sub></li></ul></td></tr><tr><td><p align=\"center\"><strong>Renal</strong></p></td><td><ul><li>&uarr; Renal blood flow &amp; urine output</li><li>&uarr; GFR, &darr; BUN &amp; serum creatinine</li><li>&uarr; HCO<sub>3</sub><sup>&minus;</sup> excretion (metabolic compensation)</li><li>&darr; Serum Na<sup>+</sup> concentration (&uarr; ADH secretion)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hematologic</strong></p></td><td><ul><li>&uarr; Prothrombotic coagulation factors</li><li>&darr; Hemoglobin concentration (dilutional anemia)</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ADH</strong> = antidiuretic hormone; <strong>BUN</strong> = blood urea nitrogen; <strong>GFR</strong> = glomerular filtration rate; <strong>RBC</strong> = red blood cell.</p></td></tr></tbody></table></div><p>This patient&#39;s laboratory results include a high pH, a low PaCO<font size=\"2\"><sub>2</sub></font>, and a low serum bicarbonate, findings consistent with <a href=\"20453\">primary respiratory alkalosis</a> with <a href=\"1216\">renal compensation</a>.&nbsp; Chronic <strong>hyperventilation</strong> is a <strong>normal</strong> physiologic change of <strong>pregnancy</strong> triggered by elevated <strong>progesterone</strong>, which stimulates respiratory drive (to meet metabolic demand) and creates the sensation of <strong>dyspnea</strong>.</p><p>Hyperventilation of pregnancy mostly involves <strong>increased tidal volume</strong> with a minimal increase in respiratory rate.&nbsp; Although the expanding uterus causes upward displacement of the resting position of the diaphragm, diaphragmatic excursion is not impaired, allowing for the increase in tidal volume.&nbsp; Hormone-induced laxity of the intercostal muscles also enlarges the thoracic cavity, further contributing to the increase in tidal volume.&nbsp; In addition to decreased PaCO<font size=\"2\"><sub>2</sub></font>, hyperventilation leads to a slightly <strong>increased PaO<font size=\"2\"><sub>2</sub></font></strong>.</p><p>Pregnant patients with <strong>isolated mild or moderate dyspnea</strong> should therefore be <strong>provided reassurance</strong> without further diagnostic testing.&nbsp; However, in the presence of findings suggesting cardiopulmonary disease, further evaluation should be performed.</p><ul><li><p>Echocardiography is indicated for the evaluation of peripartum cardiomyopathy, which manifests during the last month of pregnancy or within 5 months postdelivery (this patient is too early in pregnancy).&nbsp; Signs of decompensated heart failure (eg, lung crackles) are expected.&nbsp; This patient&#39;s systolic murmur is likely a flow murmur due to the physiologic expansion of blood volume, and her ankle edema is explained by uterine compression of the inferior vena cava <strong>(Choice B)</strong>.</p></li><li><p>Ventilation-perfusion lung scan (rather than CT angiography) is indicated for the evaluation of acute pulmonary embolism, which is expected to cause hypoxemia rather than high PaO<font size=\"2\"><sub>2</sub></font> as in this patient <strong>(Choice C)</strong>.</p></li></ul><p><strong>(Choice A)</strong>&nbsp; Measurement of urine chloride can help determine the cause of metabolic alkalosis, which is characterized by a high serum bicarbonate.&nbsp; Metabolic alkalosis can be caused by severe vomiting (eg, hyperemesis gravidarum) and would not be expected to cause dyspnea.</p><p><strong>(Choice D)</strong>&nbsp; Iron supplementation in addition to iron-containing prenatal vitamins would be appropriate for management of iron deficiency anemia.&nbsp; However, this patient&#39;s hemoglobin of 11 g/dL is normal for the second trimester of pregnancy (ie, &gt;10.5 g/dL) and is due to plasma volume expansion (ie, dilutional anemia).&nbsp; Because the oxygen-carrying capacity of blood is not reduced, dilutional anemia is unlikely to cause dyspnea.</p><p><strong>Educational objective:</strong><br>Dyspnea is common during pregnancy and is most often explained by physiologic progesterone-induced hyperventilation that leads to primary respiratory alkalosis.&nbsp; Patients without findings suggesting cardiopulmonary disease (eg, peripartum cardiomyopathy, pulmonary embolism) should be provided reassurance.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14160,
            "topic": "Normal pregnancy",
            "titleId": 14160,
            "title": "Normal pregnancy",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Measure urine chloride",
                    "choiceNumber": 1,
                    "correctTaken": 264,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain echocardiography",
                    "choiceNumber": 2,
                    "correctTaken": 487,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Order ventilation-perfusion lung scan",
                    "choiceNumber": 3,
                    "correctTaken": 2288,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe additional iron supplementation",
                    "choiceNumber": 4,
                    "correctTaken": 219,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance only",
                    "choiceNumber": 5,
                    "correctTaken": 5103,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23928384",
                    "mediaDataId": 0,
                    "title": "Renal physiology of pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23928384",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16443140",
                    "mediaDataId": 0,
                    "title": "Respiratory physiologic changes in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16443140",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 336,
            "othersAvgTimeSpent": 113,
            "notes": null,
            "peopleTaken": 8361,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 182,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 23665,
            "questionIndex": 107901,
            "questionText": "<p>A 24-year-old woman, gravida 1 para 1, is evaluated on postoperative day 2 for a headache and fatigue.&nbsp; She has no visual symptoms, chest pain, or shortness of breath.&nbsp; Two days ago, the patient underwent an emergency cesarean delivery under general anesthesia for a footling breech fetal presentation and a nonreassuring fetal heart rate status.&nbsp; She has no chronic medical conditions or prior surgeries.&nbsp; Temperature is 101 F (38.3 C), blood pressure is 136/82 mm Hg, and pulse is 118/min.&nbsp; Oxygen saturation is 97% on room air.&nbsp; Cardiac examination shows a regular rhythm.&nbsp; Lungs are without wheezes or rhonchi.&nbsp; The abdomen is soft, and the incision is intact, without induration or drainage.&nbsp; The uterus is soft, and the fundus is tender to palpation.&nbsp; The urinary catheter is in place within the urethra, and there is clear urine in the Foley bag.&nbsp; There is moderate pitting edema to the knees bilaterally.&nbsp; Which of the following interventions would have been most effective at preventing this patient&#39;s clinical presentation?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T40314\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Postpartum endometritis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Cesarean delivery</li><li>Intraamniotic infection</li><li>Group B <em>Streptococcus</em> colonization</li><li>Prolonged rupture of membranes</li><li>Operative vaginal delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Fever &gt;24 hr postpartum</li><li>Uterine fundal tenderness</li><li>Purulent lochia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Polymicrobial infection</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Clindamycin &amp; gentamicin</li></ul></td></tr></tbody></table></div><p>This patient&#39;s postpartum fever is likely due to <strong>postpartum endometritis</strong>, a polymicrobial infection of the uterine decidua that occurs due to direct bacterial inoculation of the uterine cavity during labor and delivery.&nbsp; Patients typically develop <strong>fever &gt;24 hours postpartum</strong> and uterine (eg, <strong>fundal</strong>) <strong>tenderness</strong>.&nbsp; Additional findings may include malodorous lochia (ie, purulent vaginal discharge), increased vaginal bleeding, and nonspecific fatigue or headache.</p><p>A major risk factor is cesarean delivery because it can introduce both microbial organisms (eg, skin flora) and foreign bodies (eg, suture) into the uterus.&nbsp; In addition, suture repair of the uterine incision can cause necrosis of the myometrial tissue, which may serve as a nidus for infection.</p><p><strong>Emergency cesarean delivery</strong> further increases the risk for postpartum endometritis due to the added risks of inadequate skin antisepsis and missed antibiotic prophylaxis under emergency conditions.&nbsp; The risk for surgical site infections, which includes postpartum endometritis in patients undergoing cesarean delivery, can be decreased with administration of <strong>routine preoperative antibiotics</strong> (eg, cefazolin) 30 minutes prior to skin incision.</p><p><strong>(Choice A)</strong>&nbsp; Although early catheter discontinuation (eg, on postoperative day 2) is recommended to prevent catheter-associated urinary tract infection, earlier catheter removal would not have prevented this patient&#39;s postpartum endometritis (fever, fundal tenderness).</p><p><strong>(Choice C)</strong>&nbsp; Prophylactic anticoagulation before cesarean delivery can prevent deep vein thrombosis (eg, postoperative fever, unilateral lower extremity edema) in certain high-risk patients (eg, previous venous thromboembolism, thrombophilia).&nbsp; This patient&#39;s bilateral leg edema is likely physiologic (eg, postpartum volume shifts) and not due to deep vein thrombosis.</p><p><strong>(Choice D)</strong>&nbsp; Regional neuraxial anesthesia is preferred for cesarean delivery because general anesthesia (ie, intubation) causes maternal sedation and has additional risks (eg, aspiration pneumonia).&nbsp; However, general anesthesia was necessary to expedite this patient&#39;s delivery, and her postpartum fever is likely unrelated because she has clear lungs and normal oxygen saturation.</p><p><strong>(Choice E)</strong>&nbsp; Blood pressure control during pregnancy, particularly in those with chronic hypertension, can prevent preeclampsia.&nbsp; Although this patient has a postpartum headache, her blood pressure is 136/82 mm Hg (&lt;140/90 mm Hg) and does not meet the criteria for preeclampsia.</p><p><strong>Educational objective:</strong><br>Patients with postpartum endometritis typically have fever &gt;24 hours postpartum and uterine tenderness.&nbsp; Cesarean delivery is a risk factor, but the risk can be reduced with administration of routine preoperative antibiotics (eg, cefazolin).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4174,
            "topic": "Postpartum endometritis",
            "titleId": 4174,
            "title": "Postpartum endometritis",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Early discontinuation of urinary catheterization",
                    "choiceNumber": 1,
                    "correctTaken": 1981,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preoperative antibiotics",
                    "choiceNumber": 2,
                    "correctTaken": 3761,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prophylactic anticoagulation",
                    "choiceNumber": 3,
                    "correctTaken": 368,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Regional neuraxial anesthesia",
                    "choiceNumber": 4,
                    "correctTaken": 753,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Strict blood pressure control",
                    "choiceNumber": 5,
                    "correctTaken": 540,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27512432",
                    "mediaDataId": 0,
                    "title": "Postpartum infections: a review for the non-OBGYN.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27512432",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25822271",
                    "mediaDataId": 0,
                    "title": "Cesarean delivery: counseling issues and complication management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25822271",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 397,
            "othersAvgTimeSpent": 102,
            "notes": null,
            "peopleTaken": 7403,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 13045,
            "questionIndex": 14374,
            "questionText": "<p>A 38-year-old woman, gravida 3 para 2, at 37 weeks gestation comes to the labor and delivery unit due to contractions.&nbsp; The contractions started this morning and now are painful and occur every 5 minutes.&nbsp; The patient has had no leakage of fluid or vaginal bleeding.&nbsp; Fetal movement is normal.&nbsp; Previous pregnancies ended in uncomplicated term vaginal deliveries.&nbsp; The patient has HIV that was diagnosed at her first prenatal visit during this pregnancy.&nbsp; Viral load 1 week ago was 12,300 copies/mL.&nbsp; She does not always take her combination antiretroviral medications but takes a daily prenatal vitamin.&nbsp; Blood pressure is 132/86 mm Hg and pulse is 98/min.&nbsp; The patient is tolerating labor well, and the uterus is soft and nontender between contractions.&nbsp; The fetal heart rate tracing is shown in the <a href=\"25269\">exhibit</a>.&nbsp; The cervix is 4 cm dilated and 100% effaced, and the fetal vertex is at 0 station.&nbsp; The amniotic sac is tense and palpable.&nbsp; In addition to starting zidovudine, which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T35548\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>HIV management during pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Antepartum</strong></p></td><td><ul><li>Testing of HIV-1 viral load monthly until undetectable, then every 3 months</li><li>CD4 cell count every 3 months</li><li>Resistance testing if not previously performed</li><li>Initiation or continuation of HAART</li><li>Avoidance of amniocentesis if viral load is detectable</li></ul></td></tr><tr><td><p align=\"center\"><strong>Intrapartum</strong></p></td><td><ul><li>Avoidance of artificial ROM, fetal scalp electrode, operative vaginal delivery</li><li>Viral load &#8804;50 copies/mL: ART + vaginal delivery</li><li>Viral load &gt;50 copies/mL to &#8804;1,000 copies/mL: ART &plusmn; zidovudine + vaginal delivery</li><li>Viral load &gt;1,000 copies/mL: ART + zidovudine + cesarean delivery</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HAART</strong> = highly active antiretroviral therapy; <strong>ROM</strong> = rupture of membranes.</p></td></tr></tbody></table></div><p>This patient at 37 weeks gestation with regular contractions, cervical dilation, and a category I fetal heart tracing is in early normal labor, which is typically managed expectantly.&nbsp; However, labor management (including mode of delivery) in <strong>patients with HIV</strong> differs based on <strong>maternal viral load at delivery</strong>, which determines the <strong>risk of vertical transmission</strong> to the neonate <strong>(Choice C)</strong>.</p><ul><li><p>Patients with viral loads &#8804;50 copies/mL deliver vaginally because the risk of vertical transmission is low.&nbsp; These patients do not require additional intrapartum intravenous antiretroviral therapy (ie, zidovudine) but do continue their daily antiretroviral regimens.</p></li><li><p>Patients with viral loads &gt;50 copies/mL but &#8804;1,000 copies/mL are at a slightly increased risk of vertical transmission and often receive intrapartum intravenous zidovudine along with their daily antiretroviral medications.&nbsp; However, vaginal delivery is still acceptable because transmission risk is not further reduced by cesarean delivery.</p></li><li><p>In contrast, patients with <strong>viral loads &gt;1,000 copies/mL</strong> are at <strong>high risk of vertical transmission</strong> during vaginal delivery.&nbsp; A fetus is exposed to infected maternal body fluids during passage through the vaginal canal and is at greater risk of skin barrier compromise.</p></li></ul><p>Cesarean delivery reduces perinatal HIV transmission by 50% when maternal viral load is &gt;1,000 copies/mL.&nbsp; Therefore, along with administration of <strong>intrapartum zidovudine</strong> (which also helps reduce vertical transmission rates), the best next step in this patient&#39;s management is <strong>cesarean delivery</strong>.&nbsp; The patient also should adhere to her daily antiretroviral regimen.</p><p><strong>(Choice A)</strong>&nbsp; <a href=\"8342\">Amniotomy</a>, fetal scalp electrode placement, and operative vaginal delivery are contraindicated in women with HIV, hepatitis B, or hepatitis C.&nbsp; These procedures can break the protective fetal skin barrier, increasing the risk of vertical transmission.</p><p><strong>(Choices D and E)</strong>&nbsp; Misoprostol (prostaglandin E<font size=\"2\"><sub>1</sub></font>) is used for labor induction, and oxytocin is used for labor augmentation.&nbsp; Neither is indicated in patients in normal labor (eg, regular contractions, cervical dilation).&nbsp; In addition, these medications are contraindicated in this patient because they promote vaginal delivery, which is associated with higher rates of neonatal HIV infection when maternal viral load is &gt;1,000 copies/mL at delivery.</p><p><strong>Educational objective:</strong><br>Pregnant women with HIV and viral loads &gt;1,000 copies/mL at delivery are at high risk of vertical transmission.&nbsp; These patients require cesarean delivery and intrapartum zidovudine, both of which help decrease neonatal HIV infection risk.&nbsp; In contrast, patients with viral loads &#8804;1,000 copies/mL are candidates for vaginal delivery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 11784,
            "topic": "HIV",
            "titleId": 11784,
            "title": "HIV",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amniotomy",
                    "choiceNumber": 1,
                    "correctTaken": 1273,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 2,
                    "correctTaken": 9081,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Expectant management",
                    "choiceNumber": 3,
                    "correctTaken": 4275,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Misoprostol",
                    "choiceNumber": 4,
                    "correctTaken": 318,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin",
                    "choiceNumber": 5,
                    "correctTaken": 981,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23791563",
                    "mediaDataId": 0,
                    "title": "Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23791563",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16741495",
                    "mediaDataId": 0,
                    "title": "Achievements in public health.  Reduction in perinatal transmission of HIV infectionUnited States, 1985-2005.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16741495",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 15928,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 16834,
            "questionIndex": 18280,
            "questionText": "<p>A 29-year-old woman, gravida 1 para 1, comes to the office for a postpartum visit.&nbsp; Three weeks ago, the patient had a spontaneous vaginal delivery of a 4.2-kg (9-lb 2-oz) male infant after an induction of labor for gestational hypertension.&nbsp; The patient was treated for asymptomatic bacteriuria in the first trimester but had an otherwise uncomplicated pregnancy.&nbsp; Her labor lasted 30 hours, and she pushed for 4 hours.&nbsp; Immediately after delivery, the patient developed uterine atony that resolved with intravenous oxytocin and bimanual massage.&nbsp; The patient had no additional postpartum complications and went home the next day.&nbsp; She has had light vaginal bleeding since delivery, with no passage of clots or pelvic pain.&nbsp; The patient is breastfeeding exclusively, and reports fatigue due to frequent sleep interruption, but otherwise feels well.&nbsp; Blood pressure is 122/74 mm Hg and pulse is 82/min.&nbsp; BMI is 24 kg/m&sup2;.&nbsp; Physical examination is unremarkable.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Intimate partner violence</strong> (IPV) is any type of physical, psychologic, or sexual harm committed by a partner or spouse (eg, the infant&#39;s father).&nbsp; During pregnancy and postpartum, patients and their partners experience marked increases in emotional, physical, and financial stressors (eg, new childcare responsibilities, sleep deprivation).&nbsp; Because of these stressors, the rate of IPV can <strong>increase postpartum</strong> and cause significant <strong>maternal morbidity</strong> (eg, physical injury, mental health disorders) and/or <strong>infant complications</strong> (eg, poor feeding, maltreatment).&nbsp; In addition, patients are often reluctant to disclose IPV due to denial, shame, and fear of repercussions.</p><p>Therefore, <strong>routine postpartum screening</strong> for IPV is required soon (eg, 3-6 weeks) after delivery.&nbsp; Patients who screen positive should be assessed for immediate safety and given additional resources (eg, domestic violence program referral) for long-term safety planning (eg, housing, childcare, finances).</p><p><strong>(Choice A)</strong>&nbsp; A postpartum, 2-hour (75-g) glucose tolerance test is used to screen for type 2 diabetes mellitus in patients who had gestational diabetes mellitus.&nbsp; This patient&#39;s pregnancy was not complicated by gestational diabetes mellitus.</p><p><strong>(Choice B)</strong>&nbsp; A 24-hour urine total protein collection can distinguish between gestational hypertension and preeclampsia.&nbsp; Patients with antenatal gestational hypertension (such as this patient) can develop preeclampsia up to 6 weeks postpartum; however, this patient is currently normotensive, making this diagnosis unlikely.</p><p><strong>(Choice C)</strong>&nbsp; Pelvic ultrasound can be used to assess for retained products of conception, which may present with postpartum hemorrhage (eg, heavy bleeding with passage of clots) or postpartum endometritis (eg, pelvic pain, fever, tachycardia).&nbsp; This patient has no heavy bleeding or pelvic pain, and her vital signs are normal.</p><p><strong>(Choice E)</strong>&nbsp; Urinalysis and urine culture are used to identify and treat asymptomatic bacteriuria during pregnancy because screening and treatment decrease the rate of pyelonephritis in pregnancy and preterm labor.&nbsp; In contrast, postpartum patients are not screened because screening does not change outcomes in this population.</p><p><strong>Educational objective:</strong><br>The risk of intimate partner violence (IPV) increases during the postpartum period due to increased emotional, physical, and financial stressors.&nbsp; Therefore, routine postpartum screening for IPV is required to decrease the risk of maternal and infant morbidity.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23383,
            "topic": "Postpartum complication",
            "titleId": 23383,
            "title": "Postpartum complication",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "2-hour (75 gm) glucose tolerance test",
                    "choiceNumber": 1,
                    "correctTaken": 3170,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "24-hour urine total protein collection",
                    "choiceNumber": 2,
                    "correctTaken": 1971,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic ultrasound",
                    "choiceNumber": 3,
                    "correctTaken": 2905,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Screening for intimate partner violence",
                    "choiceNumber": 4,
                    "correctTaken": 6840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinalysis and urine culture",
                    "choiceNumber": 5,
                    "correctTaken": 1909,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31619194",
                    "mediaDataId": 0,
                    "title": "Intimate partner violence identified through routine antenatal screening and maternal and perinatal health outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31619194",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18569465",
                    "mediaDataId": 0,
                    "title": "The impact of intimate partner violence on women&#39;s reproductive health and pregnancy outcome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18569465",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 210,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 16795,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 17033,
            "questionIndex": 18481,
            "questionText": "<p>A 30 year-old-woman, gravida 1 para 0, at 29 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She reports increasing fatigue, shortness of breath with exertion, and bilateral leg swelling over the past few weeks.&nbsp; The patient has had no vaginal bleeding, contractions, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; Her initial prenatal visit was at 10 weeks gestation, and results of a complete blood count at that time were as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11.8 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">240,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">8,000/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Today, blood pressure is 124/84 mm Hg, pulse is 77/min, and respirations are 22/min.&nbsp; Cardiac examination is normal, and the lungs are clear to auscultation bilaterally.&nbsp; Fundal height is 29 cm and fetal heart rate is 160/min.&nbsp; Bilateral lower extremities have 2+ pitting edema up to the knees.&nbsp; Results of a complete blood count today are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Platelets</td><td style=\"vertical-align:middle;\">118,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"vertical-align:middle;\">Leukocytes</td><td style=\"vertical-align:middle;\">8,200/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Third-trimester HIV and syphilis tests are negative.&nbsp; Which of the following is the most appropriate management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t58168\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Thrombocytopenia in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Gestational</strong></p></td><td><ul><li>Isolated, mild (100,000-150,000/mm<sup>3</sup>)</li><li>Asymptomatic</li><li>Diagnosis of exclusion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Preeclampsia with<br />severe features/<br />HELLP syndrome</strong></p></td><td><ul><li>Moderate to severe (&lt;100,000/mm<sup>3</sup>)</li><li>Hypertension &plusmn;&nbsp;headache/scotomata</li><li>&plusmn;&nbsp;&uarr;&nbsp;Creatinine, &uarr;&nbsp;AST &amp; ALT</li></ul></td></tr><tr><td><p align=\"center\"><strong>Immune-mediated<br />thrombocytopenia (ITP)</strong></p></td><td><ul><li>Isolated, moderate to severe (&lt;100,000/mm<sup>3</sup>)</li><li>Asymptomatic or mucosal bleeding/bruising</li><li>Normal PT, aPTT</li></ul></td></tr><tr><td><p align=\"center\"><strong>Thrombotic<br />thrombocytopenic<br />purpura (TTP)</strong></p></td><td><ul><li>Severe (&lt;30,000/mm<sup>3</sup>)</li><li>Neurologic symptoms (eg, confusion, seizure), fever, abdominal pain, petechiae</li><li>Normal PT, aPTT</li></ul></td></tr><tr><td><p align=\"center\"><strong>Disseminated<br />intravascular<br />coagulopathy (DIC)</strong></p></td><td><ul><li>Moderate to severe (&lt;100,000/mm<sup>3</sup>)</li><li>Bleeding (eg, oozing intravenous sites) &plusmn;&nbsp;thrombosis</li><li>&uarr;&nbsp;PT, &uarr;&nbsp;aPTT, &darr;&nbsp;fibrinogen</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ALT</strong>&nbsp;=&nbsp;alanine aminotransferase; <strong>aPTT</strong>&nbsp;=&nbsp;activated PTT;<strong> AST</strong>&nbsp;=&nbsp;aspartate aminotransferase; <strong>HELLP</strong>&nbsp;=&nbsp;<strong>H</strong>emolysis, <strong>E</strong>levated <strong>L</strong>iver enzymes, &amp; <strong>L</strong>ow <strong>P</strong>latelets.</p></td></tr></tbody></table></div><p>This patient most likely has <strong>gestational thrombocytopenia</strong>, a benign condition that causes an isolated, mild thrombocytopenia (ie, <strong>platelets 100,000-150,000/mm</strong><font size=\"2\"><sup><strong>3</strong></sup></font>).&nbsp; Gestational thrombocytopenia occurs in 5%-10% of pregnancies and is likely due to physiologic increases in plasma volume during pregnancy (ie, dilutional effect).&nbsp; It is commonly diagnosed in the <strong>third trimester</strong> on a routine complete blood count, as in this patient, but can arise as early as the first trimester.&nbsp; Patients are <strong>asymptomatic</strong> (ie, no bruising, bleeding, or anemia) or have normal physiologic symptoms of pregnancy, such as this patient&#39;s fatigue, shortness of breath, and symmetric leg swelling.</p><p>Patients with isolated, asymptomatic, and mild thrombocytopenia in pregnancy are assumed to have gestational thrombocytopenia.&nbsp; Because this condition does not affect obstetric or neonatal outcomes and because platelet counts usually normalize within 6 weeks of delivery (ie, self-limited), management includes <strong>reassurance and observation</strong>.&nbsp; In contrast, symptomatic or moderate to severe thrombocytopenia (ie, &lt;100,000/mm<font size=\"2\"><sup>3</sup></font>) requires evaluation for an alternate diagnosis (eg, thrombotic thrombocytopenic purpura).</p><p><strong>(Choice A)</strong>&nbsp; A 24-hour urine collection for total protein is used to evaluate for preeclampsia, which can cause thrombocytopenia (ie, preeclampsia with severe features).&nbsp; However, these patients typically have platelet counts &lt;100,000/mm<font size=\"2\"><sup>3</sup></font> and hypertension (ie, systolic &#8805;140 mm Hg or diastolic &#8805;90 mm Hg), which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Antinuclear antibody titers are elevated in autoimmune disorders (eg, systemic lupus erythematosus), which can be associated with immune-mediated thrombocytopenia (ITP).&nbsp; However, ITP typically causes platelet counts &lt;100,000/mm<font size=\"2\"><sup>3</sup></font>, making this diagnosis less likely.</p><p><strong>(Choice C)</strong>&nbsp; Coagulation studies can be used to evaluate patients with thrombocytopenia with abnormal bleeding or clotting (eg, disseminated intravascular coagulopathy), which is not seen in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Von Willebrand factor activity levels are used to assess for von Willebrand disease, which causes impaired platelet-endothelial binding and reduced factor VIII levels.&nbsp; However, patients typically have abnormal bleeding and normal platelet levels, making this diagnosis unlikely in this patient.</p><p><strong>Educational objective:</strong><br>Patients with gestational thrombocytopenia are asymptomatic (ie, no bruising, bleeding, or anemia) and typically have mildly reduced platelet counts of 100,000-150,000/mm<font size=\"2\"><sup>3</sup></font>.&nbsp; Gestational thrombocytopenia is benign and self-limited and is managed with reassurance and observation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 16644,
            "topic": "Thrombocytopenia",
            "titleId": 16644,
            "title": "Thrombocytopenia",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine protein collection",
                    "choiceNumber": 1,
                    "correctTaken": 3773,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody titers",
                    "choiceNumber": 2,
                    "correctTaken": 813,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Coagulation studies",
                    "choiceNumber": 3,
                    "correctTaken": 2496,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and observation",
                    "choiceNumber": 4,
                    "correctTaken": 9269,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Von Willebrand factor activity level",
                    "choiceNumber": 5,
                    "correctTaken": 310,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "666",
                    "mediaDataId": 0,
                    "title": "Thrombocytopenia: An overview",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29972751",
                    "mediaDataId": 0,
                    "title": "Platelet counts during pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29972751",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27512485",
                    "mediaDataId": 0,
                    "title": "Thrombocytopenic syndromes in pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27512485",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 157,
            "othersAvgTimeSpent": 77,
            "notes": null,
            "peopleTaken": 16661,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 27179,
            "questionIndex": 115558,
            "questionText": "<p>A 24-year-old woman, gravida 1 para 0, at 41 weeks gestation comes to the hospital with regular, painful uterine contractions.&nbsp; The patient has no chronic medical conditions, and her pregnancy has been uncomplicated.&nbsp; Fetal heart rate monitoring shows a baseline of 140/min, moderate variability, spontaneous accelerations, and no decelerations.&nbsp; On cervical examination, the cervix is 4 cm dilated and 90% effaced with the fetal vertex at 0 station.&nbsp; The patient is admitted to labor and delivery and, 1 hour later, is noted to have grossly ruptured membranes.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 115/70 mm Hg, and pulse is 100/min.&nbsp; Fetal heart rate tracing is shown in the <a href=\"4548\">exhibit</a>.&nbsp; On repeat digital cervical examination, the cervix is 7 cm dilated and 90% effaced with the fetal vertex at +1 station.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "&nbsp;<p><img  draggable=\"false\" id=\"4549\" src=\"https://www.uworld.com/media/highresdefault/L29118.jpg\"  ></p><p>This patient&#39;s fetal heart rate (FHR) tracing shows a normal baseline, moderate variability (average amplitude of 6-25/min), and <strong>recurrent variable decelerations</strong> caused by umbilical cord compression.&nbsp; Umbilical cord compression, which commonly occurs during contractions, impedes fetal-placental blood flow by occluding the umbilical blood vessels.&nbsp; Subsequent fetal hypoxemia and acidemia correlate with the ratio of umbilical cord compressions to contractions.</p><ul><li><p>Intermittent umbilical cord compression, as evidenced by variable decelerations with &lt;50% of contractions, is typically well tolerated by the fetus (ie, no hypoxemia) and does not require intervention.</p></li><li><p>In contrast, <strong>umbilical cord compression</strong> with &#8805;<strong>50% of contractions</strong> (as evidenced by recurrent variable decelerations) can result in a lack of fetal-placental blood flow and cause hypoxemia and acidemia.</p></li></ul><p>First-line management of recurrent variable decelerations is intrauterine resuscitation with <strong>maternal repositioning</strong> (eg, left lateral, all-fours), which may <strong>reduce cord compression</strong> and improve fetal-placental blood flow.&nbsp; If the variable decelerations do not improve, an <strong>amnioinfusion</strong> (ie, instillation of saline into the uterine cavity) can be administered to artificially create more amniotic fluid, which can reduce umbilical cord compression.</p><p><strong>(Choice A)</strong>&nbsp; Cesarean delivery is indicated in patients with absent variability and recurrent variable decelerations (ie, <a href=\"19564\">category III FHR tracing</a>).&nbsp; This patient&#39;s FHR tracing shows moderate variability; therefore, resuscitation should be attempted first.&nbsp; If the tracing were to become category III, cesarean delivery would be indicated.</p><p><strong>(Choice B)</strong>&nbsp; An operative vaginal delivery (eg, forceps, vacuum) can be performed to expedite delivery in the setting of a nonreassuring FHR tracing.&nbsp; It is performed only in patients with complete (10 cm) cervical dilation.</p><p><strong>(Choice D)</strong>&nbsp; Oxytocin augmentation increases contraction strength and frequency, thereby increasing cord compression and impeding fetal-placental perfusion.&nbsp; This would exacerbate the variable decelerations.</p><p><strong>(Choice E)</strong>&nbsp; Phenylephrine, a vasopressor, is often administered when initiating epidural anesthesia to prevent maternal hypotension.&nbsp; Maternal hypotension is a cause of <a href=\"14218\">late decelerations</a>, which reflect a sustained decrease in fetal-placental perfusion (as opposed to the abrupt decrease seen with cord compression and variable decelerations).&nbsp; In contrast to variable decelerations, late decelerations have a slow onset (&#8805;30 sec from onset to nadir) and are always associated with contractions.</p><p><strong>Educational objective:</strong><br>Umbilical cord compression impedes fetal-placental perfusion by occluding the umbilical blood vessels.&nbsp; Patients who have umbilical cord compression with &#8805;50% of contractions (as evidenced by recurrent variable decelerations) are at risk for fetal hypoxemia and require intervention with maternal repositioning and possible amnioinfusion.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22374,
            "topic": "Fetal heart tracing",
            "titleId": 22374,
            "title": "Fetal heart tracing",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 1,
                    "correctTaken": 780,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Forceps-assisted vaginal delivery",
                    "choiceNumber": 2,
                    "correctTaken": 225,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal repositioning",
                    "choiceNumber": 3,
                    "correctTaken": 3271,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin augmentation",
                    "choiceNumber": 4,
                    "correctTaken": 781,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phenylephrine administration",
                    "choiceNumber": 5,
                    "correctTaken": 29,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34352857",
                    "mediaDataId": 0,
                    "title": "Intrapartum resuscitation interventions for category II fetal heart rate tracings and improvement to category I.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34352857",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "10796084",
                    "mediaDataId": 0,
                    "title": "Amnioinfusion for potential or suspected umbilical cord compression in labour.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/10796084",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 89,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 5086,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 17772,
            "questionIndex": 19232,
            "questionText": "<p>A 39-year-old primigravid woman at 7 weeks gestation comes to the emergency department for vaginal bleeding.&nbsp; She has had dark brown vaginal spotting and mild uterine cramping for the past day.&nbsp; The patient has felt extreme fatigue and has had daily nausea and vomiting for the past week.&nbsp; Blood pressure is 112/68 mm Hg and pulse is 86/min.&nbsp; The abdomen is soft and without rebound or guarding.&nbsp; On pelvic examination, there is scant dark blood in the vagina, and the cervix is visually closed.&nbsp; Pelvic ultrasound is shown in the image below:</p><p><img draggable=\"false\" id=\"34349\" src=\"https://www.uworld.com/media/U45631.jpg\" ></p><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"34350\" src=\"https://www.uworld.com/media/L45631.jpg\" ></p><p>Vaginal spotting and mild abdominal cramping are common during the first trimester and are usually benign in patients with a closed cervix and an intrauterine gestation on fetal ultrasound.&nbsp; This patient has 2 intrauterine gestations, or a <strong>twin pregnancy</strong>, on ultrasound.&nbsp; Risk factors for twin gestation include increasing maternal age, fertility-enhancing therapies (eg, ovulation induction), increased parity, and family history.&nbsp; Increased first-trimester nausea and vomiting can be early indicators of a twin pregnancy and are likely due to elevated hCG and progesterone levels.</p><p>Twins are classified based on <strong>chorionicity</strong> (number of placentas) and <strong>amnionicity</strong> (number of amniotic sacs); this is best assessed during the first trimester.</p><ul><li><p>Monochorionic-monoamniotic twins (ie, 1 placenta and 1 amniotic sac) are diagnosed by a lack of a dividing intertwin membrane.</p></li><li><p>Monochorionic-diamniotic twins (ie, 1 placenta and 2 amniotic sacs) are diagnosed by a <a href=\"16506\">T sign</a>, which occurs when both amnion layers meet at the shared placenta at a 90-degree angle.</p></li><li><p>Dichorionic-diamniotic gestations (ie, 2 placentas and 2 amniotic sacs) present as either 2 visually separate placentas or the appearance of a fused placenta identified by a thick, intertwin membrane and a placental projection where the intertwin membrane meets the placenta (ie, <a href=\"16507\">lambda sign</a>).</p></li></ul><p>This patient has a <strong>dichorionic-diamniotic twin pregnancy</strong> with a lambda sign.&nbsp; Dichorionic-diamniotic twins are the most common twin gestation and have the fewest pregnancy complications of the twin gestation types.</p><p><strong>(Choice A)</strong>&nbsp; An anembryonic gestation, a pregnancy with no embryonic development, can present with vaginal spotting.&nbsp; Ultrasound typically reveals an <a href=\"19703\">empty gestational sac</a> (ie, gestational sac &#8805;25 mm with no embryo or yolk sac).</p><p><strong>(Choice B)</strong>&nbsp; A complete hydatidiform mole classically presents with a Swiss-cheese or snowstorm appearance on ultrasound rather than with 2 fetuses.</p><p><strong>(Choice C)</strong>&nbsp; An incomplete spontaneous abortion presents with vaginal bleeding and cervical dilation with visible products of conception at the cervix or vagina.&nbsp; This patient&#39;s cervix is closed.</p><p><strong>(Choice D)</strong>&nbsp; An ultrasound of a normal singleton gestation with fibroid would reveal a single embryo and a separate, well-circumscribed, hypoechoic mass with shadowing, which is not seen on this patient&#39;s ultrasound.</p><p><strong>Educational objective:</strong><br>Dichorionic-diamniotic twin pregnancies are identified on ultrasound with 2 intrauterine gestations, 2 placentas, and 2 amniotic sacs.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12216,
            "topic": "Multiple gestation",
            "titleId": 12216,
            "title": "Multiple gestation",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anembryonic gestation",
                    "choiceNumber": 1,
                    "correctTaken": 201,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Complete hydatidiform mole",
                    "choiceNumber": 2,
                    "correctTaken": 169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Incomplete spontaneous abortion",
                    "choiceNumber": 3,
                    "correctTaken": 776,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal singleton gestation with fibroid",
                    "choiceNumber": 4,
                    "correctTaken": 679,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Twin gestation",
                    "choiceNumber": 5,
                    "correctTaken": 10216,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30479634",
                    "mediaDataId": 0,
                    "title": "Ultrasound surveillance in twin pregnancy: an update for practitioners.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30479634",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29536536",
                    "mediaDataId": 0,
                    "title": "Role of ultrasonography in the management of twin gestation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29536536",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 64,
            "othersAvgTimeSpent": 38,
            "notes": null,
            "peopleTaken": 12041,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 85,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 17339,
            "questionIndex": 18794,
            "questionText": "<p>A 10-hour-old boy is evaluated for jitteriness.&nbsp; The patient was born at 38 weeks gestation to a 36-year-old primigravid woman via cesarean delivery due to nonreassuring fetal heart tones.&nbsp; Pregnancy was complicated by maternal gestational diabetes.&nbsp; Birth weight was 4.5 kg (9 lb 14 oz).&nbsp; Apgar scores were 7 and 9 at 1 and 5 minutes, respectively.&nbsp; After birth, the patient had low blood glucose, which was treated appropriately.&nbsp; He has not yet had a bowel movement.&nbsp; The patient is afebrile with normal pulse and blood pressure.&nbsp; Oxygen saturation is 98% on room air.&nbsp; Examination shows a jittery neonate.&nbsp; Cardiopulmonary examination is unremarkable.&nbsp; There is no increased work of breathing, cyanosis, or tachypnea.&nbsp; The abdomen is soft, nontender, and nondistended.&nbsp; The remainder of the examination is unremarkable.&nbsp; Blood glucose is 65 mg/dL.&nbsp; Which of the following is the most appropriate next step in evaluation of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t66775\"><table class=\"table-default-style\" style=\"width:588px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Neonatal complications of diabetes during pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Maternal hyperglycemia&nbsp;&rarr; fetal hyperglycemia &rarr; &beta;-cell hyperplasia &amp; hyperinsulinemia</li><li>&uarr; Fetal fat &amp; glycogen stores</li><li>&uarr; Fetal metabolic demand</li></ul></td></tr><tr><td><p align=\"center\"><strong>Associated<br />risks</strong></p></td><td><ul><li>Prematurity</li><li>Congenital anomalies (eg,&nbsp;caudal regression syndrome)</li><li>Macrosomia &amp; associated complications (eg,&nbsp;brachial plexus injury, clavicle fracture)</li><li>Respiratory distress syndrome</li><li>Hypertrophic cardiomyopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Hypoglycemia</li><li>Polycythemia, low iron</li><li>Hypocalcemia &amp; hypomagnesemia</li><li>Hyperbilirubinemia</li></ul></td></tr></tbody></table></div><p>The most common cause of jitteriness in <strong>infants of diabetic mothers</strong> (IDMs) is <strong>hypoglycemia</strong>.&nbsp; However, this patient&#39;s serum glucose is now normal (&#8805;40 mg/dL), making <strong>hypocalcemia</strong> the most likely cause.&nbsp; The pathophysiology of hypocalcemia in IDMs relates to maternal <strong>hypomagnesemia</strong>, which is caused by osmotic diuresis in the setting of poorly controlled gestational diabetes.&nbsp; Low fetal magnesium concentrations, which reflect maternal levels, lead to PTH suppression and low calcium levels in the neonate.</p><p>Most newborns with hypocalcemia are asymptomatic; normalization of calcium levels usually occurs without intervention within days of birth, so routine screening is not required.&nbsp; However, <strong>symptomatic hypocalcemia</strong> can present with <strong>jitteriness</strong>, respiratory symptoms (eg, apnea, stridor from laryngospasm, wheezing from bronchospasm), and, if severe, seizures.&nbsp; Additional findings in IDMs may reflect consequences of excessive, maternally transferred glucose, such as increased fetal fat and glycogen storage leading to macrosomia in the infant (as seen here).</p><p>If hypoglycemia in symptomatic IDMs is resolved, a <strong>serum calcium level</strong> should be obtained to confirm the diagnosis of hypocalcemia.&nbsp; Management typically involves correction of magnesium and then calcium.</p><p><strong>(Choice A)</strong>&nbsp; Abdominal x-ray may be indicated for delayed passage of meconium (age &gt;48 hr), which can occur in IDMs due to a slight risk of small left colon syndrome (ie, transient dysmotility condition).&nbsp; This patient&#39;s abdominal examination is benign, and lack of stool is normal for his age.</p><p><strong>(Choice B)</strong>&nbsp; Arterial blood gas for assessment of oxygenation is indicated for respiratory distress syndrome, the risk of which is slightly increased in IDMs because fetal hyperinsulinemia can suppress surfactant production.&nbsp; However, patients typically have tachypnea, increased work of breathing (eg, retractions, grunting), and hypoxia, not seen here.</p><p><strong>(Choice C)</strong>&nbsp; Echocardiography is performed for suspected transient hypertrophic cardiomyopathy, an uncommon complication in IDMs due to glycogen deposition in the interventricular septum.&nbsp; This condition would not cause jitteriness, and a systolic murmur at the lower left sternal border due to left ventricular outflow tract obstruction would be expected.</p><p><strong>(Choice D)</strong>&nbsp; Preterm infants and those with macrosomia are at increased risk of neonatal hyperbilirubinemia, which can cause jitteriness if severe, but scleral icterus and marked jaundice would be present.&nbsp; Moreover, this condition does not typically occur on the first day of life.</p><p><strong>Educational objective:</strong><br>Metabolic complications of infants of diabetic mothers include hypoglycemia, hypocalcemia, and hypomagnesemia.&nbsp; Serum calcium level should be obtained for symptomatic neonates (eg, jitteriness), particularly if serum glucose is normal.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 12169,
            "topic": "Large for gestational age",
            "titleId": 12169,
            "title": "Large for gestational age",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Abdominal x-ray",
                    "choiceNumber": 1,
                    "correctTaken": 1665,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Arterial blood gas",
                    "choiceNumber": 2,
                    "correctTaken": 3119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiography",
                    "choiceNumber": 3,
                    "correctTaken": 2016,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum bilirubin level",
                    "choiceNumber": 4,
                    "correctTaken": 2500,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum calcium level",
                    "choiceNumber": 5,
                    "correctTaken": 7004,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31320908",
                    "mediaDataId": 0,
                    "title": "Clinical approach to hypocalcemia in newborn period and infancy: who should be treated?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31320908",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 299,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 16304,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 4666,
            "questionIndex": 4666,
            "questionText": "<p>Three days after an uncomplicated cesarean delivery, a 23-year-old woman, gravida 1 para 1, is evaluated on the postpartum floor due to bilateral breast pain and fatigue.&nbsp; The patient has been attempting to breastfeed but has had difficulty getting the infant to latch, requiring her to supplement with formula.&nbsp; The patient&#39;s pregnancy was complicated by insulin-controlled gestational diabetes mellitus.&nbsp; She had a progestin-containing subcutaneous implant placed a day ago for contraception.&nbsp; Temperature is 37.4 C (99.4 F), blood pressure is 130/70 mm Hg, and pulse is 100/min.&nbsp; Bilateral breasts are full, erythematous, and diffusely tender.&nbsp; There is no axillary lymphadenopathy.&nbsp; The uterine fundus is firm, nontender, and palpable 3 cm below the umbilicus.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36901\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Common problems related to lactation</strong></p></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Engorgement</strong></p></td><td><p>Bilateral, symmetric fullness, tenderness &amp; warmth</p></td></tr><tr><td><p align=\"center\"><strong>Nipple injury</strong></p></td><td><p>Abrasion, bruising, cracking &amp;/or blistering from poor latch</p></td></tr><tr><td><p align=\"center\"><strong>Plugged duct</strong></p></td><td><p>Focal tenderness &amp; firmness &amp;/or erythema; no fever</p></td></tr><tr><td><p align=\"center\"><strong>Galactocele</strong></p></td><td><p>Subareolar, mobile, well-circumscribed, nontender mass; no fever</p></td></tr><tr><td><p align=\"center\"><strong>Mastitis</strong></p></td><td><p>Tenderness/erythema + fever</p></td></tr><tr><td><p align=\"center\"><strong>Abscess</strong></p></td><td><p>Symptoms of mastitis + fluctuant mass</p></td></tr></tbody></table></div><p>This patient has <strong>breast engorgement</strong>, which commonly <strong>occurs 3-5 days after delivery</strong>, when colostrum is replaced by milk, resulting in high milk production volumes.&nbsp; The engorgement is exacerbated by a physiologic increase in interstitial edema from decreasing progesterone levels after delivery.&nbsp; Engorgement may also occur during times when milk accumulation exceeds drainage (eg, breastfeeding weaning).&nbsp; Patients with breast engorgement have <strong>bilateral breast fullness</strong> with <strong>diffuse tenderness and erythema</strong>.&nbsp; Cool compresses, acetaminophen, and nonsteroidal anti-inflammatory drugs may be used for symptom control.&nbsp; Patients should experience improvement as breastfeeding or regular pumping is established.</p><p><strong>(Choices A and D)</strong>&nbsp; In contrast to this patient, those with <a href=\"4479\">lactational mastitis</a> often have flulike symptoms (eg, fever, myalgias) and unilateral breast pain with a focal area of erythema and tenderness.&nbsp; Breast abscesses appear like mastitis and an associated area of fluctuance and axillary lymphadenopathy.</p><p><strong>(Choices C and F)</strong>&nbsp; A <a href=\"5048\">galactocele</a> and plugged ducts are common problems in breastfeeding women, but both typically present as a palpable mass.</p><p><strong>(Choice E)</strong>&nbsp; Mammary candidosis is a common breastfeeding complication.&nbsp; Patients typically have unilateral, stabbing breast pain that is out of proportion to examination and have associated scaling of the skin on the nipple of the affected breast.</p><p><strong>Educational objective:</strong><br>Breast engorgement is common 3-5 days after delivery when colostrum is replaced by milk.&nbsp; Symptoms include bilateral breast fullness, tenderness, and warmth, without fever.&nbsp; Improvement is expected as breastfeeding is established.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4016,
            "topic": "Breast engorgement",
            "titleId": 4016,
            "title": "Breast engorgement",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Breast abscess",
                    "choiceNumber": 1,
                    "correctTaken": 45,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Breast engorgement",
                    "choiceNumber": 2,
                    "correctTaken": 13761,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Galactocele",
                    "choiceNumber": 3,
                    "correctTaken": 216,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lactational mastitis",
                    "choiceNumber": 4,
                    "correctTaken": 2003,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mammary candidosis",
                    "choiceNumber": 5,
                    "correctTaken": 87,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plugged duct",
                    "choiceNumber": 6,
                    "correctTaken": 701,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20824853",
                    "mediaDataId": 0,
                    "title": "Treatments for breast engorgement during lactation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20824853",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25774443",
                    "mediaDataId": 0,
                    "title": "Pathological postpartum breast engorgement: prediction, prevention, and resolution.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25774443",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26512442",
                    "mediaDataId": 0,
                    "title": "Breast pain: engorgement, nipple pain, and mastitis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26512442",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 89,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 16813,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 17226,
            "questionIndex": 18678,
            "questionText": "<p>A 30-year-old woman, gravida 1 para 0, at 26 weeks gestation comes to the office for a routine prenatal visit.&nbsp; She has had no contractions, vaginal bleeding, or leakage of fluid.&nbsp; Fetal movement is normal.&nbsp; The patient has no chronic medical conditions, and her only medications are a prenatal vitamin and iron supplement.&nbsp; Prepregnancy BMI was 18 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; She has gained less than the recommended 0.5 kg (1 lb) per week.&nbsp; Vital signs are normal.&nbsp; Fetal heart rate is 150/min.&nbsp; Fundal height is 24 cm.&nbsp; Ultrasound reveals a fetus measuring in the 25th percentile for gestational age.&nbsp; This patient is at increased risk for which of the following pregnancy-related complications?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t58686\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Weight gain in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Prepregnancy<br />BMI (kg/m<sup>2</sup>)</strong></p></td><td><p align=\"center\"><strong>Ideal weight gain</strong></p></td><td><p align=\"center\"><strong>Complications</strong></p></td></tr><tr><td><p align=\"center\">&lt;18.5</p></td><td><p align=\"center\">12.7-18.1 kg (28-40 lb)</p></td><td rowspan=\"4\"><p>Inadequate weight gain</p><ul><li>Low birth weight</li><li>Preterm delivery</li></ul><p>Excessive weight gain</p><ul><li>Gestational diabetes mellitus</li><li>Fetal macrosomia</li><li>Cesarean delivery</li></ul></td></tr><tr><td><p align=\"center\">18.5-24.9</p></td><td><p align=\"center\">11.3-15.9 kg (25-35 lb)</p></td></tr><tr><td><p align=\"center\">25-29.9</p></td><td><p align=\"center\">6.8-11.3 kg (15-25 lb)</p></td></tr><tr><td><p align=\"center\">&ge;30</p></td><td><p align=\"center\">5-9 kg (11-20 lb)</p></td></tr></tbody></table></div><p>During pregnancy, women have increased nutritional requirements because both calories and nutrients (eg, folate, calcium, iron) are preferentially shunted to the developing fetus.&nbsp; To meet these metabolic demands, average women should increase their intake by approximately 350-450 kcal/day in the second and third trimesters.</p><p>The target goals for gestational weight gain depend on prepregnancy BMI, which is an indicator of baseline maternal fat and nutrient stores.&nbsp; Patients with an <strong>underweight prepregnancy BMI</strong> (ie, &lt;18.5 kg/m<font size=\"2\"><sup>2</sup></font>) have low baseline stores and therefore require greater weight gain (~1 lb [0.5 kg]/week) to maintain a healthy pregnancy.</p><p>This patient is both underweight and has had <strong>inadequate gestational weight gain</strong>, which along with the lagging fundal height (eg, 24 cm at 26 weeks gestation) and fetal growth in the 25th percentile suggest that this patient&#39;s nutrition may become insufficient for appropriate fetal development.&nbsp; This depleted state increases the risk for <strong>pregnancy-related complications</strong>, including <strong>preterm delivery</strong> (which occurs when patients can no longer shunt enough nutrients to support the fetus) and <strong>low birth weight</strong> (ie, small for gestational age infant).</p><p><strong>(Choices A and E)</strong>&nbsp; Women with a high prepregnancy BMI (eg, &#8805;30 kg/m<font size=\"2\"><sup>2</sup></font>) and excessive gestational weight gain are at increased risk of cesarean delivery due to higher rates of gestational diabetes mellitus, fetal macrosomia, and labor dystocia.&nbsp; Obesity also increases the risk of hypertension and preeclampsia due to increased systemic vascular resistance.</p><p><strong>(Choice B)</strong>&nbsp; Unlike adult anemia, which is commonly due to iron deficiency (eg, inadequate nutrition, blood loss), fetal anemia typically occurs due to fetal red blood cell destruction (ie, hemolysis).&nbsp; Common causes include Rh alloimmunization, which is caused by maternal autoantibodies against fetal red blood cells, and parvovirus B19 infection, which is cytotoxic to fetal red blood cell precursors.</p><p><strong>(Choice C)</strong>&nbsp; Risk factors for <a href=\"2778\">placenta previa</a> include prior cesarean delivery (due to uterine scarring) and multiple gestation (due to increased placental surface area).</p><p><strong>(Choice D)</strong>&nbsp; Risk factors for <a href=\"2483\">placental abruption</a> include abdominal trauma and conditions that disrupt the vascular integrity of the placenta (eg, maternal hypertension, smoking, cocaine use).&nbsp; Inadequate gestational weight gain is not associated with placental abruption.</p><p><strong>Educational objective:</strong><br>Patients with an underweight prepregnancy BMI and inadequate gestational weight gain are at increased risk of pregnancy-related complications (eg, low birth weight, preterm delivery).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14160,
            "topic": "Normal pregnancy",
            "titleId": 14160,
            "title": "Normal pregnancy",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cesarean delivery",
                    "choiceNumber": 1,
                    "correctTaken": 540,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fetal anemia",
                    "choiceNumber": 2,
                    "correctTaken": 4680,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placenta previa",
                    "choiceNumber": 3,
                    "correctTaken": 226,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placental abruption",
                    "choiceNumber": 4,
                    "correctTaken": 402,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preeclampsia",
                    "choiceNumber": 5,
                    "correctTaken": 391,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Preterm delivery",
                    "choiceNumber": 6,
                    "correctTaken": 14094,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31477075",
                    "mediaDataId": 0,
                    "title": "Gestational weight gain outside the Institute of Medicine recommendations and adverse pregnancy outcomes: analysis using individual participant data from randomised trials.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31477075",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29160923",
                    "mediaDataId": 0,
                    "title": "Pregnancy weight gain by gestational age and stillbirth: a population-based cohort study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29160923",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28586887",
                    "mediaDataId": 0,
                    "title": "Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28586887",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 88,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 20333,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 17272,
            "questionIndex": 18725,
            "questionText": "<p>A 32-year-old woman, gravida 4 para 3, at 8 weeks gestation comes to the office to establish prenatal care.&nbsp; She has had no bleeding or cramping.&nbsp; The patient has type 1 diabetes mellitus diagnosed at age 12 and uses an insulin pump.&nbsp; Her most recent hemoglobin A1c was 6.8%.&nbsp; Six months ago, she started a daily exercise routine of weight lifting and running on a treadmill.&nbsp; Her first pregnancy was a cesarean delivery at term gestation for breech presentation.&nbsp; The patient then had 2 painless, second-trimester deliveries consistent with cervical insufficiency.&nbsp; Vital signs are normal.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On pelvic examination, the cervix is closed and there is no vaginal bleeding.&nbsp; Transvaginal ultrasound reveals an 8-week intrauterine gestation with positive heart tones.&nbsp; The patient asks if she can continue her current exercise program.&nbsp; Which of the following is this patient&#39;s contraindication to exercise in pregnancy?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T47571\"><table class=\"table-default-style\" style=\"width:602px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pregnancy &amp; exercise</strong></p></td></tr><tr><td><p align=\"center\"><strong>Absolute</strong></p><p align=\"center\"><strong>contraindications</strong></p></td><td><ul><li>Amniotic fluid leak</li><li>Cervical insufficiency</li><li>Multiple gestation</li><li>Placenta abruption or previa</li><li>Premature labor</li><li>Preeclampsia/gestational hypertension</li><li>Severe heart or lung disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Unsafe</strong></p><p align=\"center\"><strong>activities</strong></p></td><td><ul><li>Contact sports (eg, basketball, ice hockey, soccer)</li><li>High fall risk (eg, downhill skiing, gymnastics, horseback riding)</li><li>Scuba diving</li><li>Hot yoga</li></ul></td></tr></tbody></table></div><p><strong>Exercise during pregnancy</strong> can be beneficial and is associated with decreased risks of excessive gestational weight gain, gestational diabetes mellitus, preeclampsia, and cesarean delivery.&nbsp; Therefore, low-risk patients who exercised regularly prior to pregnancy are encouraged to continue moderate-intensity exercise during pregnancy.</p><p>However, exercise during pregnancy may exacerbate some obstetric conditions; therefore, it is <strong>contraindicated</strong> in certain patients.&nbsp; Exercise should be avoided by:</p><ul><li><p>Patients at <strong>high risk for preterm birth</strong></p><ul><li><strong>Cervical insufficiency</strong> or cerclage</li><li>Preterm labor during current pregnancy</li><li>Preterm prelabor rupture of membranes</li></ul></li><li><p>Patients at risk for <strong>antepartum bleeding</strong></p><ul><li><a href=\"4268\">Placenta previa</a></li><li>Persistent second- or third-trimester bleeding</li></ul></li><li><p>Patients with an <strong>underlying condition</strong> that could be <strong>exacerbated by exercise</strong></p><ul><li>Severe anemia (eg, hemoglobin &lt;8 g/L)</li><li>Hypertensive disorders of pregnancy (eg, preeclampsia)</li><li>Restrictive lung disease</li><li>Hemodynamically significant heart disease</li></ul></li></ul><p><strong>Cervical insufficiency</strong> is a cervical structural weakness associated with <strong>painless second-trimester pregnancy loss</strong>.&nbsp; Patients with cervical insufficiency (eg, based on a history of 2 prior losses) are at a high risk for recurrent pregnancy loss.&nbsp; This risk can be decreased by placing a <a href=\"1307\">prophylactic cerclage</a> (a suture placed around the cervix to reinforce its stability) and avoidance of moderate- to high-intensity exercise such as running and weight lifting <strong>(Choice C)</strong>.</p><p><strong>(Choices B and E)</strong>&nbsp; During pregnancy, both type 1 and type 2 diabetes mellitus are associated with an increased risk of preeclampsia and abnormal fetal growth (eg, macrosomia, growth restriction), depending on placental function and maternal glycemic control.&nbsp; Regular exercise, along with prevention of excessive gestational weight gain, can reduce these risks.&nbsp; A normal BMI (eg, 23 kg/m<font size=\"2\"><sup>2</sup></font>) is not a contraindication to exercise.</p><p><strong>(Choice D)</strong>&nbsp; Prior cesarean delivery is not a contraindication to exercise.</p><p><strong>(Choice F)</strong>&nbsp; Pregnant patients should avoid exercises that increase the risk of abdominal trauma and maternal injury (eg, contact sports, downhill skiing).&nbsp; Hot yoga is also not recommended due to the risks of hyperthermia (eg, fetal neural tube defects).&nbsp; Most other types of exercise, including running and moderate weight lifting, may be continued in pregnancy.</p><p><strong>Educational objective:</strong><br>Moderate-intensity exercise is recommended for most pregnant women.&nbsp; However, exercise is contraindicated in patients who are at high risk for preterm birth (eg, cervical insufficiency), have antepartum bleeding, or have an underlying medical condition that could be exacerbated by exercise.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19194,
            "topic": "Prenatal Care",
            "titleId": 19194,
            "title": "Prenatal Care",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "History of cervical insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 9821,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal BMI",
                    "choiceNumber": 2,
                    "correctTaken": 19,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No contraindication to exercise",
                    "choiceNumber": 3,
                    "correctTaken": 3899,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prior cesarean delivery",
                    "choiceNumber": 4,
                    "correctTaken": 178,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Type 1 diabetes mellitus",
                    "choiceNumber": 5,
                    "correctTaken": 199,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Type of exercise",
                    "choiceNumber": 6,
                    "correctTaken": 2756,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "32217980",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 804: physical activity and exercise during pregnancy and the postpartum period.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/32217980",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24452558",
                    "mediaDataId": 0,
                    "title": "Hot yoga and pregnancy: fitness and hyperthermia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24452558",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 79,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 16872,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 17510,
            "questionIndex": 18967,
            "questionText": "<p>A 34-year-old woman, gravida 2 para 1, at 30 weeks gestation comes to the emergency department due to a severe, unilateral headache.&nbsp; The patient has a history of migraine headaches, and earlier today she developed a severe, throbbing headache on the right side of the head.&nbsp; She drank a can of caffeinated soda and tried to rest in a dark room, but the headache has not improved.&nbsp; The patient has had no nausea, vomiting, or changes in vision.&nbsp; She has no other chronic medical conditions, takes no daily medications, and has no known drug allergies.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 126/82 mm Hg, and pulse is 92/min.&nbsp; Fetal heart rate is 150/min.&nbsp; Neurologic examination is normal.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Urine dipstick is negative for protein.&nbsp; Which of the following is the most appropriate initial pharmacotherapy for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"14119\" src=\"https://www.uworld.com/media/L38332.jpg\" ></p><p>During <strong>pregnancy</strong>, headaches are common and typically benign.&nbsp; Headaches with atypical features (eg, altered mental status, neurologic deficits) or in patients &#8805;20 weeks gestation require evaluation to exclude other etiologies, such as preeclampsia or cerebral venous thrombosis, due to risk of adverse maternal (eg, stroke, disseminated intravascular coagulation) and fetal (eg, growth restriction, demise) outcomes.&nbsp; This patient has a throbbing, <strong>unilateral headache</strong> without changes in vision, consistent with a typical <strong>migraine without aura</strong>.</p><p>Management of migraines in pregnancy is complicated due to limited therapeutic options.</p><ul><li><p><strong>Acetaminophen</strong> is the preferred <strong>first-line</strong> option; patients also typically benefit from caffeine and limiting exposure to light and sound (eg, resting in a dark room).</p></li><li><p>In patients <strong>who do not improve</strong> with acetaminophen alone, a low-potency opioid (eg, <strong>acetaminophen-codeine</strong>), antiemetics (eg, promethazine), or caffeine/butalbital may be beneficial.</p></li><li><p>More potent opioids (eg, oxycodone) are typically not used due to their tendency to worsen gastrointestinal symptoms (eg, constipation, nausea) during pregnancy; however, they can be considered if all other options fail to improve symptoms <strong>(Choice E)</strong>.</p></li></ul><p>Parenteral antiemetics (eg, metoclopramide) are used acutely and are effective monotherapy.</p><p><strong>(Choice B)</strong>&nbsp; Ergotamine is an effective migraine medication but is contraindicated in pregnancy due to risk of hypertonic uterine contractions and vasoconstriction, which can lead to adverse obstetric outcomes (eg, preterm labor, fetal growth restriction).&nbsp; Triptans (eg, sumatriptan) are also typically avoided in pregnancy due to risk of uteroplacental vasoconstriction, increased uterotonic activity, preterm delivery, and low birth weight.</p><p><strong>(Choice C)</strong>&nbsp; Nonsteroidal anti-inflammatory drugs (eg, ibuprofen) can be used for headaches refractory to acetaminophen, but they are typically avoided in the first and third trimesters due to the risk of fetal complications (eg, spontaneous abortion, premature ductus arteriosus closure, oligohydramnios, renal dysfunction).</p><p><strong>(Choice D)</strong>&nbsp; Magnesium sulfate is used for seizure prophylaxis in patients with preeclampsia with severe features (eg, new-onset hypertension at &#8805;20 weeks gestation with headache or vision changes).&nbsp; This patient is normotensive and has no proteinuria, making this diagnosis unlikely.&nbsp; Magnesium sulfate for migraine treatment has more limited efficacy.</p><p><strong>Educational objective:</strong><br>Acetaminophen is the first-line treatment option for migraines during pregnancy.&nbsp; Second- and third-line options include addition of opioids (eg, acetaminophen-codeine), antiemetics, and nonsteroidal anti-inflammatory drugs (in the second trimester only).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 24490,
            "topic": "Migraine",
            "titleId": 24490,
            "title": "Migraine",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acetaminophen",
                    "choiceNumber": 1,
                    "correctTaken": 12214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ergotamine",
                    "choiceNumber": 2,
                    "correctTaken": 2430,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ibuprofen",
                    "choiceNumber": 3,
                    "correctTaken": 3352,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate",
                    "choiceNumber": 4,
                    "correctTaken": 1300,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxycodone",
                    "choiceNumber": 5,
                    "correctTaken": 147,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29052046",
                    "mediaDataId": 0,
                    "title": "Headache and pregnancy: a systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29052046",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29671521",
                    "mediaDataId": 0,
                    "title": "Acute migraine headache: treatment strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29671521",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 19443,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 11209,
            "questionIndex": 12361,
            "questionText": "<p>A 25-year-old woman, gravida 2 para 1, at 20 weeks gestation comes to the office in mid-September for a routine prenatal visit.&nbsp; The patient has felt normal fetal movement and has had no abdominal pain, vaginal bleeding, or leakage of fluid.&nbsp; Three days ago, her 5-year-old son was diagnosed with varicella; however, the patient has not had fever, malaise, or rash.&nbsp; She has no chronic medical conditions and has had no previous surgeries.&nbsp; The patient takes a prenatal vitamin and an iron supplement daily.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Blood pressure is 110/60 mm Hg and pulse is 64/min.&nbsp; BMI is 27 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows no rash or lymphadenopathy.&nbsp; Fundal height is appropriate for gestational age.&nbsp; The fetal heart rate by bedside Doppler ultrasound is 145/min.&nbsp; The patient&#39;s prenatal laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Rubella IgG</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Rubella IgM</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Varicella-zoster IgG</td><td style=\"vertical-align:middle;\">positive</td></tr><tr><td style=\"vertical-align:middle;\">Varicella-zoster IgM</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Blood type</td><td style=\"vertical-align:middle;\">B, Rh negative</td></tr><tr><td style=\"vertical-align:middle;\">Antibody screen</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Which of the following should be administered to the patient at this visit?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31283\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vaccines during pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Recommended</strong></p></td><td><ul><li>Tdap</li><li>Inactivated influenza</li><li>Rho(D) immunoglobulin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Indicated for<br>high-risk patients</strong></p></td><td><ul><li>Hepatitis B</li><li>Hepatitis A</li><li>Pneumococcus</li><li><em>Haemophilus influenzae</em></li><li>Meningococcus</li><li>Varicella-zoster immunoglobulin</li></ul></td></tr><tr><td><p align=\"center\"><strong>Contraindicated</strong></p></td><td><ul><li>HPV</li><li>MMR</li><li>Live attenuated influenza</li><li>Varicella</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>HPV</strong> = human papillomavirus; <strong>MMR</strong> = measles-mumps-rubella; <strong>Tdap</strong> = tetanus toxoid&ndash;reduced diphtheria toxoid&ndash;acellular pertussis.</p></td></tr></tbody></table></div><p>Vaccinations during pregnancy are indicated if the vaccine has minimal risk, if significant risk exists for infection exposure, and if increased morbidity and mortality are associated with infection.&nbsp; <strong>Vaccines</strong> that are <strong>safe during pregnancy</strong> include <strong>immunoglobulins</strong> (eg, anti-D immunoglobulin), <strong>toxoids</strong> (eg, tetanus toxoid), and <strong>inactivated vaccines</strong> (eg,<em> </em>intramuscular influenza).&nbsp; In contrast, live attenuated vaccines (eg, intranasal influenza) are contraindicated during pregnancy due to the theoretical risk of congenital infection.</p><p>Pregnant women are at increased risk for morbidity (eg, pneumonia) and mortality from the influenza virus.&nbsp; <strong>All pregnant women</strong> without contraindications should receive the seasonal influenza vaccination as soon as it becomes available.&nbsp; The <strong>inactivated influenza vaccine</strong> is <strong>safe during every trimester</strong> of pregnancy and while breastfeeding.&nbsp; This vaccine prevents maternal influenza-related illness and provides passive neonatal immunity, thereby decreasing the risk of influenza-related illness in newborns.</p><p><strong>(Choice A)</strong>&nbsp; Rh-negative pregnant women without indications for earlier administration (eg, trauma, vaginal bleeding) receive standard anti&ndash;D immunoglobulin prophylaxis for alloimmunization prevention at 28 weeks gestation, which covers potential sensitizing events in the third trimester until delivery.</p><p><strong>(Choice C)</strong>&nbsp; This patient is not immune to rubella, as evidenced by negative IgG and IgM serologies.&nbsp; The measles-mumps-rubella (MMR) vaccine is a live attenuated vaccine and is contraindicated during pregnancy.&nbsp; This patient should be vaccinated in the immediate postpartum period to prevent future infection.</p><p><strong>(Choice D)</strong>&nbsp; The tetanus-diphtheria-pertussis vaccine (Tdap) is indicated in every pregnancy, but it is ideally administered at 27-36 weeks gestation to allow transplacental maternal antibody transfer and facilitate neonatal immunity.&nbsp; Vaccination at 20 weeks gestation results in suboptimal antibody levels in the newborn due to waning maternal antibody production.</p><p><strong>(Choices E and F)</strong>&nbsp; Varicella in pregnancy can cause maternal complications (eg, pneumonia, meningitis, encephalitis) and congenital anomalies (eg, cicatricial lesions, cataracts, chorioretinitis).&nbsp; Patients who are exposed to varicella but lack evidence of varicella immunity (eg, negative IgG antibody, no history of childhood infection) are treated with postexposure prophylaxis.&nbsp; In pregnancy, postexposure prophylaxis includes varicella-zoster immunoglobulin administration.&nbsp; The live attenuated varicella-zoster vaccine is contraindicated during pregnancy.&nbsp; This patient has had a recent varicella exposure, but her testing suggests immunity (ie, positive varicella IgG antibodies) and requires no further treatment.</p><p><strong>Educational objective:</strong><br>Vaccines that are safe during pregnancy include inactivated influenza, tetanus-diphtheria-pertussis (Tdap), and anti-D immunoglobulin.&nbsp; The inactivated seasonal influenza vaccine is safe throughout pregnancy and should be administered as soon as it becomes available.&nbsp; Tdap and anti-D immunoglobulin should be administered during the third trimester.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 16546,
            "topic": "Immunizations",
            "titleId": 16546,
            "title": "Immunizations",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "2",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Intramuscular anti&ndash;D immunoglobulin",
                    "choiceNumber": 1,
                    "correctTaken": 897,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular influenza vaccine",
                    "choiceNumber": 2,
                    "correctTaken": 8582,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular measles-mumps-rubella vaccine",
                    "choiceNumber": 3,
                    "correctTaken": 1253,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular tetanus-diphtheria-pertussis vaccine",
                    "choiceNumber": 4,
                    "correctTaken": 884,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular varicella vaccine",
                    "choiceNumber": 5,
                    "correctTaken": 2811,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intramuscular varicella-zoster immunoglobulin",
                    "choiceNumber": 6,
                    "correctTaken": 779,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29578983",
                    "mediaDataId": 0,
                    "title": "Committee opinion no. 732:  influenza vaccination during pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29578983",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 223,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 15206,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 16065,
            "questionIndex": 17507,
            "questionText": "<p>A 27-year-old woman, gravida 1 para 1, comes to the office for evaluation of postpartum bleeding.&nbsp; Four days ago, the patient had a forceps-assisted vaginal delivery due to recurrent fetal decelerations.&nbsp; She had a third-degree perineal laceration that was repaired, and she went home on the second postpartum day.&nbsp; Since delivery, the patient has had continuous, dark red vaginal bleeding with small clots, requiring her to change a menstrual pad 6 to 7 times daily.&nbsp; She has no chest pain, shortness of breath, or orthostasis.&nbsp; Temperature is 99.5 F (37.5 C), blood pressure is 124/76 mm Hg, and pulse is 88/min.&nbsp; BMI is 33 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The uterine fundus is firm, nontender, and palpable at 4 cm below the umbilicus.&nbsp; The perineal laceration repair is intact, and the cervix is 1 cm dilated with minimal dark red blood in the vagina.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"width:69.95pt;\">Hemoglobin</td><td style=\"width:65.7pt;\">10 g/dL</td></tr><tr><td style=\"width:69.95pt;\">Platelets</td><td style=\"width:65.7pt;\">140,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td style=\"width:69.95pt;\">Leukocytes</td><td style=\"width:65.7pt;\">11,000/mm<font size=\"2\"><sup>3</sup></font></td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41573\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Normal postpartum lochia*</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Expected duration</strong></p></td><td><p align=\"center\"><strong>Description</strong></p></td></tr><tr><td><p align=\"center\"><strong>Lochia<br />rubra</strong></p></td><td><ul><li>Birth to 3-4&nbsp;days postpartum</li></ul></td><td><ul><li>Dark or bright red (blood); odor similar to that of menstrual blood; occasional small clots; quantity decreasing each day</li></ul></td></tr><tr><td><p align=\"center\"><strong>Lochia<br />serosa</strong></p></td><td><ul><li>4th postpartum day to 10th or 14th postpartum day</li></ul></td><td><ul><li>Serosanguineous (pink); brownish (old blood); quantity gradually decreasing in amount</li></ul></td></tr><tr><td><p align=\"center\"><strong>Lochia<br />alba</strong></p></td><td><ul><li>11th postpartum day to 6&nbsp;weeks postpartum</li></ul></td><td><ul><li>White/yellow; creamy; light quantity</li></ul></td></tr><tr><td colspan=\"3\"><p>*Lochia may increase in quantity after breastfeeding (suckling releases oxytocin&nbsp;&amp; causes uterus to contract)&nbsp;&amp; 7-14&nbsp;days postpartum, when scabbing on the placental site sloughs off (heavier bleeding for &lt;2 hr); lochia may also feel increased after lying down&nbsp;&amp; then standing (due to blood pooling in vagina).</p></td></tr></tbody></table></div><p>After delivery, the uterus contracts, becoming smaller and compressing the placental bed vessels to protect against immediate postpartum hemorrhage.&nbsp; In the following days to weeks <strong>postpartum</strong>, uterine involution continues and a slow process of <strong>endometrial shedding</strong> and <strong>regeneration</strong> takes place, resulting in physiologic vaginal bleeding known as <strong>lochia</strong>.&nbsp; Lochia typically transitions from red/brown bleeding with small clots (lochia rubra, days 0-4 postpartum), to light serosanguinous bleeding (lochia serosa, days 4-14), and finally to white discharge (lochia alba).</p><p>Patients often have concerns about postpartum bleeding because it is heavier and more prolonged than normal menses.&nbsp; These patients should be evaluated for features concerning for delayed postpartum hemorrhage, including the following:</p><ul><li>Passage of large blood clots</li><li><a href=\"5954\">Increased pad counts</a> (eg, saturation of &#8805;1 pad/hr for &#8805;2 consecutive hours)</li><li>Signs and symptoms of anemia (eg, dizziness, chest pain) due to acute blood loss</li></ul><p>In contrast, this patient with passage of small clots, normal vital signs, a benign examination (eg, firm uterus, intact perineal repair), and an appropriate postpartum hemoglobin level likely has <strong>normal lochia</strong>.&nbsp; Therefore, the best next step in management is <strong>observation and reassurance</strong> that this bleeding is normal and may last for up to <strong>6 to 8 weeks postpartum</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Broad-spectrum antibiotics are administered for postpartum endometritis, which can present with heavy lochia but typically causes fever, malodorous vaginal discharge, and uterine tenderness, which are not seen in this patient.</p><p><strong>(Choice B)</strong>&nbsp; Dilation and curettage is indicated for postpartum hemorrhage due to retained placenta or membranes.&nbsp; These patients typically have a soft, boggy uterus (ie, atony).&nbsp; This patient&#39;s uterine fundus is firm, making this diagnosis less likely.</p><p><strong>(Choice D)</strong>&nbsp; Postpartum quantitative &#946;-hCG levels are used to evaluate for gestational trophoblastic neoplasia, which typically presents with heavy uterine bleeding several weeks after a molar pregnancy.&nbsp; &#946;-hCG levels are not measured immediately after a normal delivery because they typically take weeks to return to normal.</p><p><strong>(Choice E)</strong>&nbsp; Reduced von Willebrand factor activity (ie, von Willebrand disease) can cause delayed postpartum hemorrhage due to impaired platelet-endothelial binding and reduced factor VIII levels.&nbsp; This patient has no signs of delayed postpartum hemorrhage (eg, large blood clots, increased pad counts, symptomatic anemia).</p><p><strong>Educational objective:</strong><br>Lochia is physiologic vaginal bleeding after delivery due to endometrial shedding and regeneration.&nbsp; It can last up to 6 to 8 weeks postpartum.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14027,
            "topic": "Normal postpartum",
            "titleId": 14027,
            "title": "Normal postpartum",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Broad-spectrum antibiotics",
                    "choiceNumber": 1,
                    "correctTaken": 704,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dilation and curettage",
                    "choiceNumber": 2,
                    "correctTaken": 3477,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observation and reassurance",
                    "choiceNumber": 3,
                    "correctTaken": 8609,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quantitative &#946;-hCG test",
                    "choiceNumber": 4,
                    "correctTaken": 595,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Von Willebrand factor activity test",
                    "choiceNumber": 5,
                    "correctTaken": 3352,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23101487",
                    "mediaDataId": 0,
                    "title": "Lochia patterns among normal women: a systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23101487",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20417483",
                    "mediaDataId": 0,
                    "title": "Puerperal loss (lochia) in women with or without inherited bleeding disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20417483",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 228,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 16737,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 15163,
            "questionIndex": 16587,
            "questionText": "<p>A 25-year-old woman, gravida 2 para 2, comes to the office for a postpartum visit and contraception.&nbsp; Two weeks ago, the patient had a vaginal delivery at 36 weeks gestation.&nbsp; She is breastfeeding exclusively with no issues.&nbsp; Lochia has decreased, and she has no pelvic pain.&nbsp; The patient would like to start reliable contraception as soon as possible because she conceived while breastfeeding after her first pregnancy.&nbsp; She takes daily iron supplementation for iron deficiency anemia due to heavy menstrual bleeding.&nbsp; The patient has no other chronic medical conditions and takes no other medications.&nbsp; Vital signs are normal.&nbsp; Pelvic examination is deferred.&nbsp; Which of the following is the best contraceptive option for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"4937\" src=\"https://www.uworld.com/media/highresdefault/L25373.jpg\"  ></p><p>The choice of <strong>postpartum contraception</strong> is based on time from delivery, breastfeeding status, patient-specific risk factors, and desire for future fertility.&nbsp; In patients who are &lt;1 month postpartum, estrogen-containing contraceptives are avoided because they increase the <strong>risk for thromboembolism</strong> (due to estrogen-induced hypercoagulability) and can negatively affect breastfeeding <strong>(Choice A)</strong>.</p><p>Nonhormonal (eg, copper-containing intrauterine device [IUD]) and progestin-only contraception methods are preferred in patients <strong>&lt;1 month postpartum and breastfeeding</strong>.&nbsp; However, in this patient with heavy menstrual bleeding complicated by anemia, the copper-containing IUD may increase menstrual bleeding and worsen the preexisting anemia <strong>(Choice B)</strong>.&nbsp; In contrast, progestin-only contraception methods help decrease menstrual bleeding while also providing contraception.</p><p>In this patient who desires <strong>reliable</strong> contraception to avoid another short-interval pregnancy, the best contraceptive option is a progesterone-based, long-acting, reversible contraceptive such as the <strong>subdermal progestin-releasing implant</strong> or the progestin-releasing IUD.&nbsp; These methods have high efficacy (&gt;99%) for pregnancy prevention and do not increase thromboembolic risk or affect breastfeeding.&nbsp; They can be inserted immediately postpartum and kept in place for up to 3-7 years.&nbsp; In addition, they decrease menstrual bleeding and can cause amenorrhea, thereby reducing the risk for anemia due to blood loss from heavy menses.</p><p><strong>(Choice C)</strong>&nbsp; Condoms and the diaphragm are barrier methods of contraception that do not affect thromboembolic risk or breastfeeding.&nbsp; However, they have poor contraceptive efficacy (82%).</p><p><strong>(Choice D)</strong>&nbsp; Progestin-only oral contraceptives do not affect breastfeeding or thromboembolic risk.&nbsp; However, they are less effective (91%) for pregnancy prevention than the subdermal progestin-releasing implant due to high rates of user error and short medication half-life, which requires that the pill be taken at the same time daily to be effective.</p><p><strong>Educational objective:</strong><br>In postpartum patients who are breastfeeding, progestin-only contraception methods (eg, subdermal progestin-releasing implant, progestin-releasing IUD) are preferred and may be initiated immediately because they do not increase thromboembolism risk or affect breastfeeding.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 17805,
            "topic": "Contraception",
            "titleId": 17805,
            "title": "Contraception",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Combined estrogen/progestin oral contraceptive pills",
                    "choiceNumber": 1,
                    "correctTaken": 2966,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Copper-containing intrauterine device",
                    "choiceNumber": 2,
                    "correctTaken": 4036,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diaphragm and condoms",
                    "choiceNumber": 3,
                    "correctTaken": 1209,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Progestin-only oral contraceptive pills",
                    "choiceNumber": 4,
                    "correctTaken": 3925,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subdermal progestin-releasing implant",
                    "choiceNumber": 5,
                    "correctTaken": 8186,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30681544",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin no. 206: use of hormonal contraception in women with coexisting medical conditions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30681544",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27467196",
                    "mediaDataId": 0,
                    "title": "U.S. medical eligibility criteria for contraceptive use, 2016.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27467196",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 78,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 20328,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 4528,
            "questionIndex": 4528,
            "questionText": "<p>A 32-year-old woman, gravida 2 para 1, at 28 weeks gestation comes to the office for a routine prenatal visit.&nbsp; The patient has had no abdominal pain or vaginal bleeding.&nbsp; Fetal movement has been normal.&nbsp; The pregnancy has been uncomplicated thus far.&nbsp; The patient has no chronic medical conditions, and the only medication is a daily prenatal vitamin.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Vital signs are normal.&nbsp; Fetal heart rate is 145/min.&nbsp; Fundal height is 28 cm.&nbsp; Urine dipstick shows trace protein and no glucose.&nbsp; The first-trimester prenatal laboratory testing results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">HIV</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Rapid plasma reagin</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Rubella</td><td style=\"vertical-align:middle;\">nonimmune</td></tr><tr><td style=\"vertical-align:middle;\">Hepatitis B surface antigen</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Chlamydia</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Blood type</td><td style=\"vertical-align:middle;\">A, Rh-negative</td></tr><tr><td style=\"vertical-align:middle;\">Indirect Coombs test</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">Urine culture</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T32531\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td><p align=\"center\"><strong>Indications for prophylactic administration of anti-D<br>immunoglobulin for Rh D-negative patients<sup>*</sup></strong></p></td></tr><tr><td><ul><li>At 28-32 weeks gestation</li><li>&lt;72 hours after delivery of Rh D-positive infant</li><li>&lt;72 hours after spontaneous abortion</li><li>Ectopic pregnancy</li><li>Threatened abortion</li><li>Hydatidiform mole</li><li>Chorionic villus sampling, amniocentesis</li><li>Abdominal trauma</li><li>2nd- &amp; 3rd-trimester bleeding</li><li>External cephalic version&nbsp;</li></ul></td></tr><tr><td><p>*Antepartum prophylaxis is not indicated if the father is Rh D-negative.</p></td></tr></tbody></table></div><p>At the first prenatal visit, patients are routinely tested for blood type, Rh D status, and the presence of any red blood cell antibodies (antibody screen or indirect Coombs test).&nbsp; The antibody screen may be positive in women who have formed antibodies from exposure to another&#39;s blood (eg, blood transfusion, prior pregnancy).&nbsp; This process of forming positive antibodies is called <a href=\"1151\">alloimmunization or sensitization</a>.&nbsp; The antibody screen is particularly important in an <strong>Rh D-negative multiparous woman</strong>&nbsp;(such as this patient) to evaluate for anti-D antibodies that may have formed in response to a prior pregnancy with an <strong>Rh D-positive fetus</strong>.</p><p><strong>Anti-D immunoglobulin</strong> reduces the risk for alloimmunization if the fetus is Rh D-positive, which remains unknown until birth.&nbsp; Anti-D immunoglobulin is prophylactically administered at <strong>28 weeks gestation</strong> because it persists for 12 weeks and protects against any potential exposure to fetal red blood cells through the third trimester.&nbsp; It is given again <strong>within 72 hours of delivery</strong> if the baby is Rh D-positive.</p><p>This woman&#39;s <strong>negative antibody screen</strong> in the first trimester indicates that she is <strong>not alloimmunized</strong>.&nbsp; However, prior to prophylactic administration of anti-D immunoglobulin, <strong>another antibody screen</strong> (ie, <strong>indirect Coombs test</strong>) is indicated to ensure that spontaneous alloimmunization has not occurred because anti-D immunoglobulin provides no benefit in previously sensitized patients.&nbsp; In addition, identification of alloimmunization allows for appropriate management of complications (eg, <a href=\"23610\">hydrops fetalis</a>).</p><p><strong>(Choice A)</strong>&nbsp; Another screening for chlamydia in the third trimester is recommended only for high-risk individuals (eg, multiple sex partners, age &lt;25).&nbsp; This patient is low risk.</p><p><strong>(Choice B)</strong>&nbsp; Group B <em>Streptococcus</em> (GBS) rectovaginal culture is performed at 36-38 weeks gestation to identify women at risk for transmitting GBS to the neonate during vaginal delivery.&nbsp; Maternal GBS colonization is transient; therefore, cultures are obtained closer to the anticipated delivery date.</p><p><strong>(Choice D)</strong>&nbsp; The measles-mumps-rubella (MMR) vaccine is live attenuated and therefore contraindicated during pregnancy.&nbsp; It is administered postpartum to nonimmune women.</p><p><strong>(Choice E)</strong>&nbsp; All women undergo urine culture screening at the initial prenatal visit to identify asymptomatic bacteriuria because it can progress to pyelonephritis.&nbsp; Another urine culture is indicated only for high-risk patients (eg, sickle cell disease) or those with urinary symptoms.</p><p><strong>Educational objective:</strong><br>Rh(D)-negative pregnant patients not previously alloimmunized (eg, negative indirect Coombs test) require anti-D immunoglobulin to prevent Rh D alloimmunization.&nbsp; Anti-D immunoglobulin is universally administered at 28 weeks gestation following a repeat negative antibody screen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 15363,
            "topic": "Rhesus alloimmunization",
            "titleId": 15363,
            "title": "Rhesus alloimmunization",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<em>Chlamydia trachomatis</em> nucleic acid amplification test",
                    "choiceNumber": 1,
                    "correctTaken": 8582,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Group B <em>Streptococcus</em> culture",
                    "choiceNumber": 2,
                    "correctTaken": 1319,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Indirect Coombs test",
                    "choiceNumber": 3,
                    "correctTaken": 1490,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rubella immunization",
                    "choiceNumber": 4,
                    "correctTaken": 1205,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urine culture",
                    "choiceNumber": 5,
                    "correctTaken": 1259,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28742673",
                    "mediaDataId": 0,
                    "title": "Practice bulletin no. 181: prevention of Rh D alloimmunization.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28742673",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25899660",
                    "mediaDataId": 0,
                    "title": "Haemolytic disease of the fetus and newborn.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25899660",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 174,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 13855,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 11,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 4759,
            "questionIndex": 4759,
            "questionText": "<p>A 20-year-old woman comes to the emergency department due to vaginal bleeding and lower abdominal pain that began 3 days ago.&nbsp; The patient describes the bleeding as heavier than a period; she passed some vaginal clots a few hours ago.&nbsp; Menarche was at age 13, and she has often gone months without a menstrual period.&nbsp; The patient&#39;s last menstrual period was approximately 7 weeks ago.&nbsp; She is sexually active and uses condoms for contraception.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 120/74 mm Hg, and pulse is 80/min.&nbsp; Abdominal examination shows mild lower abdominal tenderness but no rebound or guarding.&nbsp; On speculum examination, there is no active vaginal bleeding, and the cervical os is closed.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">11 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">&#946;-hCG</td><td style=\"vertical-align:middle;\">1,000 mIU/mL</td></tr><tr><td style=\"vertical-align:middle;\">Blood type</td><td style=\"vertical-align:middle;\">AB</td></tr><tr><td style=\"vertical-align:middle;\">Rh factor</td><td style=\"vertical-align:middle;\">positive</td></tr></tbody></table><p>A transvaginal ultrasound does not visualize an intrauterine pregnancy, free fluid, or adnexal masses.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"4539\" src=\"https://www.uworld.com/media/highresdefault/L16263.png\"  ></p><p>This patient with vaginal bleeding and positive &#946;-hCG has <strong>first-trimester bleeding</strong>, which requires evaluation with transvaginal ultrasonography (TVUS) and serum &#946;-hCG measurements to determine pregnancy location.&nbsp; This patient&#39;s ultrasound is nondiagnostic (eg, no intrauterine pregnancy, free fluid, or adnexal masses), which is expected because her quantitative &#946;-hCG level (ie, 1,000 mIU/mL) is below the threshold at which an intrauterine pregnancy can be visualized by TVUS (ie, <strong>below the discriminatory zone</strong> [&#946;-hCG &lt;3,500 mIU/mL]).&nbsp; Therefore, she has a <strong>pregnancy of unknown location</strong>.</p><p>The most common cause of a pregnancy of unknown location is early gestation of a normal intrauterine pregnancy; however, other potential etiologies are a completed spontaneous abortion, nonviable intrauterine pregnancy (missed abortion), and ectopic pregnancy, all of which require further evaluation for definitive diagnosis <strong>(Choice D)</strong>.&nbsp; Because each type of pregnancy follows a characteristic &#946;-hCG pattern, <strong>quantitative &#946;-hCG levels</strong> are repeated <strong>every 48 hours</strong>:</p><ul><li><p>Early but viable intrauterine pregnancies typically have a &#8805;35%-50% rise in &#946;-hCG every 48 hours.</p></li><li><p>Completed spontaneous abortions cause &#946;-hCG levels to decrease precipitously because the pregnancy has been evacuated.</p></li><li><p>Ectopic and nonviable intrauterine pregnancies (eg, anembryonic gestations) usually cause &lt;35% rise in &#946;-hCG due to abnormal pregnancy development.</p></li></ul><p>Patients typically require serial quantitative &#946;-hCG measurements until the level reaches the discriminatory zone, at which point a repeat transvaginal ultrasound is performed <strong>(Choice F)</strong>.&nbsp; Those with an abnormally rising &#946;-hCG level require close follow-up due to the risk of ectopic pregnancy.</p><p><strong>(Choice A)</strong>&nbsp; Anti-D immunoglobulin is administered to Rh(D)-negative patients after pregnancy-related bleeding (eg, spontaneous abortion, ectopic pregnancy) due to the risk of <a href=\"1151\">Rh(D) alloimmunization</a> and hemolytic disease of the newborn in future pregnancies.&nbsp; This patient is Rh(D) positive.</p><p><strong>(Choices B and C)</strong>&nbsp; Methotrexate and diagnostic laparoscopy are treatment options for ectopic pregnancy, which has not been definitively diagnosed in this patient.&nbsp; Methotrexate is typically used in patients with an unruptured ectopic pregnancy.&nbsp; Diagnostic laparoscopy is performed in patients with hemodynamic instability (ie, ruptured ectopic pregnancy) or patients with contraindications to methotrexate (eg, immunodeficiency, breastfeeding).</p><p><strong>Educational objective</strong>:<br>Patients with vaginal bleeding and positive &#946;-hCG require transvaginal ultrasonography to determine pregnancy location.&nbsp; Patients with a nondiagnostic ultrasound result (eg, no intrauterine pregnancy, free fluid, or adnexal masses) require a repeat quantitative &#946;-hCG level in 48 hours to evaluate for potential ectopic pregnancy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4099,
            "topic": "Ectopic pregnancy",
            "titleId": 4099,
            "title": "Ectopic pregnancy",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Anti-D immunoglobulin",
                    "choiceNumber": 1,
                    "correctTaken": 426,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy",
                    "choiceNumber": 2,
                    "correctTaken": 564,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Methotrexate administration",
                    "choiceNumber": 3,
                    "correctTaken": 1397,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and observation only",
                    "choiceNumber": 4,
                    "correctTaken": 1398,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat quantitative &#946;-hCG in 48 hours",
                    "choiceNumber": 5,
                    "correctTaken": 10307,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transabdominal ultrasound",
                    "choiceNumber": 6,
                    "correctTaken": 2628,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27166462",
                    "mediaDataId": 0,
                    "title": "Early pregnancy bleeding.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27166462",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18515537",
                    "mediaDataId": 0,
                    "title": "ACOG practice bulletin No. 94: medical management of ectopic pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18515537",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 159,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 16720,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 11356,
            "questionIndex": 12510,
            "questionText": "<p>A 38-year-old woman, gravida 5 para 5, is evaluated for difficult and painful ambulation on postpartum day 1.&nbsp; The patient has no pain while lying down but reports sharp lower midline abdominal pain that radiates down her legs while ambulating.&nbsp; She has voided twice without difficulty and has no dysuria.&nbsp; She has passed flatus but has had no bowel movement since delivery.&nbsp; She has not had numbness or foot drop.&nbsp; The patient received epidural analgesia during labor and had a vaginal delivery of a 4400 g (9 lb 8 oz) infant that was complicated by a shoulder dystocia relieved by the McRoberts maneuver and suprapubic pressure.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 120/80 mm Hg, pulse is 90/min, and respirations are 18/min.&nbsp; Neurologic examination shows normal strength, sensation, and reflexes of the lower extremities.&nbsp; Abdominal examination shows focal tenderness to palpation just inferior to the bladder.&nbsp; Pelvic examination reveals normal lochia, no vaginal masses, and a nontender uterine fundus just below the umbilicus.&nbsp; There is moderate edema bilaterally in the lower extremities but no pain or erythema.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31753\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Pubic symphysis diastasis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Fetal macrosomia</li><li>Multiparity</li><li>Precipitous labor</li><li>Operative vaginal delivery</li></ul></td></tr><tr><td><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Difficulty ambulating</li><li>Radiating suprapubic pain</li><li>Pubic symphysis tenderness</li><li>Intact neurologic examination</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Conservative</li><li>Nonsteroidal anti-inflammatory drugs</li><li>Physical&nbsp;therapy</li><li>Pelvic support</li></ul></td></tr></tbody></table></div><p>During pregnancy, increased levels of progesterone and relaxin increase pelvic mobility and promote a physiologic widening (diastasis) of the pubic symphysis to facilitate vaginal delivery.&nbsp; However, after a <strong>traumatic delivery</strong>, patients can develop a symptomatic <strong>pubic symphysis diastasis</strong>.&nbsp; Risk factors include <strong>fetal macrosomia</strong>, forceps-assisted vaginal delivery, and multiparity.</p><p>Symptomatic pubic symphysis diastasis typically presents with <strong>suprapubic pain</strong> that <strong>radiates</strong> to the back, hips, thighs, or legs and is <strong>exacerbated by walking</strong>, weight-bearing, or position changes.&nbsp; The diagnosis is made clinically; patients have <strong>point tenderness to palpation</strong> over the pubic symphysis and sometimes have a waddling gait.&nbsp; Management is typically conservative with supportive care (eg, pelvic support, physical therapy), and most patients recover within the first 4 weeks postpartum.</p><p><strong>(Choice A)</strong>&nbsp; Epidural abscess, a complication of epidural analgesia, typically presents with back/spinal pain, fever, and focal neurologic deficits, none of which are seen this patient.</p><p><strong>(Choice B)</strong>&nbsp; Femoral nerve damage can occur during delivery as a result of hyperflexion of the thigh (eg, <a href=\"1126\">McRoberts maneuver</a>).&nbsp; It presents with numbness over the anterior and medial thigh, inability to extend the leg or flex the hip, and diminished patellar reflexes, none of which are seen in this patient.</p><p><strong>(Choice C)</strong>&nbsp; Herniated intervertebral disks present with back, rather than suprapubic, pain that often radiates down the lower extremities and with focal neurologic deficits.</p><p><strong>(Choice D)</strong>&nbsp; Pelvic abscess is a complication of cesarean delivery that typically presents with suprapubic or pelvic pain and a fever that is unresponsive to antibiotics.&nbsp; This patient had a vaginal delivery and is afebrile.</p><p><strong>(Choice F)</strong>&nbsp; A retroperitoneal hematoma occurs as a result of injury to branches of the internal iliac artery during delivery.&nbsp; Clinical manifestations include hemodynamic instability, a palpable mass, and possibly fever.&nbsp; This patient is hemodynamically stable, making this diagnosis unlikely.</p><p><strong>(Choice G)</strong>&nbsp; Sciatica, a lumbosacral radiculopathy, typically presents with low back or unilateral hip pain that radiates down the lower extremity.&nbsp; Patients have associated motor and sensory deficits on examination.&nbsp; This patient&#39;s intact neurologic examination makes this diagnosis less likely.</p><p><strong>Educational objective:</strong><br>Pubic symphysis diastasis can occur after a traumatic delivery and presents with radiating suprapubic pain that is exacerbated by ambulation or weight-bearing.&nbsp; Treatment is conservative with supportive care.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14027,
            "topic": "Normal postpartum",
            "titleId": 14027,
            "title": "Normal postpartum",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Epidural abscess",
                    "choiceNumber": 1,
                    "correctTaken": 353,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Femoral neuropathy",
                    "choiceNumber": 2,
                    "correctTaken": 1463,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Herniated intervertebral disk",
                    "choiceNumber": 3,
                    "correctTaken": 382,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic abscess",
                    "choiceNumber": 4,
                    "correctTaken": 219,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pubic symphysis diastasis",
                    "choiceNumber": 5,
                    "correctTaken": 12617,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Retroperitoneal hematoma",
                    "choiceNumber": 6,
                    "correctTaken": 620,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sciatica",
                    "choiceNumber": 7,
                    "correctTaken": 1193,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25816704",
                    "mediaDataId": 0,
                    "title": "Peripartum pubic symphysis separation--current strategies in diagnosis and therapy and presentation of two cases.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25816704",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 113,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 16847,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 18828,
            "questionIndex": 20305,
            "questionText": "<p>A 28-year-old woman, gravida 1 para 0, comes to the office to establish prenatal care.&nbsp; The patient is at 16 weeks gestation by a sure, regular last menstrual period.&nbsp; She had nausea and vomiting for a few weeks, but her symptoms have gradually improved.&nbsp; The patient has had no vaginal bleeding or cramping.&nbsp; She has no chronic medical conditions and has not been taking a prenatal vitamin because she thinks it caused her nausea.&nbsp; The patient underwent a cold knife conization 2 years ago for cervical intraepithelial neoplasia 3 but her subsequent Pap tests were negative.&nbsp; Family history is significant for her sister developing gestational diabetes mellitus during her last pregnancy.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 100/64 mm Hg, and pulse is 72/min.&nbsp; BMI is 22 kg/m&sup2;.&nbsp; Fetal heart rate is 140/min by Doppler ultrasound.&nbsp; Cardiopulmonary examination is normal.&nbsp; The abdomen is soft, nontender, and nondistended.&nbsp; On pelvic examination, there are no cervical lesions or abnormal discharge.&nbsp; Uterine size is consistent with 16 weeks gestation.&nbsp; In addition to routine laboratory testing, which of the following interventions is indicated in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"40221\" src=\"https://www.uworld.com/media/highresdefault/L66297.png\"  ></p><p>During the initial prenatal visit, risk factors for potential obstetric complications are assessed to allow for the implementation of preventive measures.</p><p>This patient with a prior <a href=\"11644\">cold knife conization</a> is at risk for <strong>preterm delivery</strong> (ie, delivery at &lt;37 weeks gestation).&nbsp; Preterm delivery is a common obstetric complication and a leading cause of neonatal morbidity and mortality.&nbsp; The greatest risk factor for preterm delivery is prior spontaneous preterm delivery, but additional risk factors include tobacco use, multiple gestation, and <strong>prior cervical surgery</strong>.&nbsp; In particular, removal of part of the cervix by <strong>cold knife conization</strong> for cervical intraepithelial neoplasia can cause cervical shortening and scarring, which decreases cervical tensile strength and increases the risk for preterm labor.</p><p>For patients with no prior preterm delivery, a <strong>transvaginal ultrasound cervical length measurement</strong> is recommended at <strong>16-24 weeks gestation</strong> to assess the risk for preterm delivery <strong>(Choice D)</strong>.&nbsp; Patients with a normal cervical length are at a lower risk for preterm delivery and require no additional intervention.&nbsp; In contrast, those with a short cervix (ie, cervical length &#8804;2.5 cm on ultrasound) are at high risk for preterm delivery and are offered vaginal progesterone, which can prevent uterine contractions and preterm labor.</p><p><strong>(Choice A)</strong>&nbsp; A 24-hour urine total protein collection is performed at &lt;20 weeks gestation to establish a baseline measurement in patients at high risk for preeclampsia (eg, chronic hypertension, diabetes mellitus).&nbsp; This patient has a normal blood pressure and no risk factors for preeclampsia.</p><p><strong>(Choice B)</strong>&nbsp; Early glucose challenge testing screens for undiagnosed pregestational diabetes mellitus (DM) and is indicated in patients with BMI &#8805;25 kg/m<font size=\"2\"><sup>2</sup></font> and an additional risk factor (eg, prior gestational DM, first-degree relative with type 2 DM).&nbsp; A first-degree relative with prior gestational DM is not an indication for early testing.</p><p><strong>(Choice C)</strong>&nbsp; High-dose (4 mg) folic acid is indicated in patients at increased risk for fetal neural tube defects (eg, prior affected pregnancy).&nbsp; This patient is at average risk.&nbsp; In addition, neural tube closure is generally complete by 5-6 weeks gestation; therefore, initiating folic acid at 16 weeks gestation is unlikely to affect neural tube outcomes.</p><p><strong>Educational objective:</strong><br>Pregnant patients with prior cervical surgery (eg, cold knife conization) are at increased risk for preterm delivery.&nbsp; These patients require a transvaginal ultrasound cervical length measurement at 16-24 weeks gestation to guide potential preventive measures (eg, vaginal progesterone).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 4239,
            "topic": "Preterm labor",
            "titleId": 4239,
            "title": "Preterm labor",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine total protein collection",
                    "choiceNumber": 1,
                    "correctTaken": 488,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Early glucose challenge testing",
                    "choiceNumber": 2,
                    "correctTaken": 1688,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High-dose (4 mg) folic acid supplementation",
                    "choiceNumber": 3,
                    "correctTaken": 4392,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional interventions indicated",
                    "choiceNumber": 4,
                    "correctTaken": 2085,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transvaginal ultrasound cervical length measurement",
                    "choiceNumber": 5,
                    "correctTaken": 8076,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29095502",
                    "mediaDataId": 0,
                    "title": "Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29095502",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21278880",
                    "mediaDataId": 0,
                    "title": "Prediction and prevention of preterm birth after cervical conization.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21278880",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 154,
            "othersAvgTimeSpent": 69,
            "notes": null,
            "peopleTaken": 16729,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 14209,
            "questionIndex": 15617,
            "questionText": "<p>A 36-year-old woman, gravida 1 para 0, at 36 weeks gestation is undergoing induction of labor due to preeclampsia with severe features.&nbsp; The patient is receiving a magnesium sulfate infusion for seizure prophylaxis and an oxytocin infusion for labor augmentation.&nbsp; She had spontaneous rupture of membranes with clear fluid 4 hours ago.&nbsp; Epidural anesthesia was placed due to increasingly painful contractions, and the patient now has adequate pain relief.&nbsp; She has a history of hypothyroidism that has been poorly controlled during pregnancy.&nbsp; Temperature is 39.4 C (102.9 F), blood pressure is 150/90 mm Hg, and pulse is 114/min.&nbsp; The cervix is 6 cm dilated and 80% effaced, and the fetal vertex is at &#8722;1 station.&nbsp; Fetal heart rate tracing is shown below.</p><p><img  draggable=\"false\" id=\"20708\" src=\"https://www.uworld.com/media/highresdefault/U31736.png\"  ></p><p>Which of the following is the most likely cause of this patient&#39;s fetal heart rate tracing?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T46438\" style=\"overflow-x:auto;\"><table class=\"table-default-style\" style=\"width:61.08%\"><tbody><tr><td colspan=\"2\" style=\"width:100.0%;\"><p align=\"center\"><strong>Baseline fetal heart rate</strong></p></td></tr><tr><td style=\"width:31.36%;\"><p align=\"center\"><strong>Fetal tachycardia<br>(&gt;160/min)</strong></p></td><td style=\"width:68.64%;\"><ul><li>Maternal fever (eg, intraamniotic infection)</li><li>Medication adverse effect (eg, beta agonists)</li><li>Fetal hyperthyroidism</li><li>Fetal tachyarrhythmia</li></ul></td></tr><tr><td style=\"width:31.36%;\"><p align=\"center\"><strong>Fetal bradycardia<br>(&lt;110/min)</strong></p></td><td style=\"width:68.64%;\"><ul><li>Maternal hypothermia</li><li>Medication adverse effect (eg, beta blockers)</li><li>Fetal hypothyroidism</li><li>Fetal heart block (eg, anti-Ro/SSA, anti-La/SSB)</li></ul></td></tr></tbody></table></div><p>This fetal heart rate tracing shows <strong>fetal tachycardia</strong>, a fetal heart rate with a baseline <strong>&gt;160/min</strong>.&nbsp; <a href=\"6271\">Fetal tachycardia</a> is associated with medication adverse effects (eg, beta agonists) and fetal hyperthyroidism; however, the most common cause, particularly during labor, is <strong>maternal fever</strong> from <strong>intraamniotic infection</strong> (IAI) (chorioamnionitis) because the temperature elevation and increased metabolic demand associated with the infection stimulate both maternal and fetal heart rate elevations.</p><p>IAI occurs due to polymicrobial vaginal bacteria ascending into the uterus during labor.&nbsp; Patients have maternal fever &#8805;39 C (in the absence of another clear cause), leukocytosis (&gt;15,000/mm<font size=\"2\"><sup>3</sup></font>), and/or purulent amniotic fluid.&nbsp; The risk for IAI increases as labor progresses and after membrane rupture, as in this patient.&nbsp; Treatment is with antipyretic therapy, broad-spectrum antibiotics, and delivery (eg, induction, augmentation) to prevent fetal morbidity (eg, sepsis, cerebral palsy) and mortality.</p><p><strong>(Choice A)</strong>&nbsp; Poorly controlled maternal hypothyroidism is associated with pregnancy complications (eg, preeclampsia, impaired fetal cognitive development).&nbsp; However, congenital hypothyroidism is typically caused by fetal thyroid dysgenesis, not maternal thyroid dysfunction, and fetal monitoring is usually normal or has signs of metabolic slowing (eg, fetal bradycardia &lt;110/min).</p><p><strong>(Choice B)</strong>&nbsp; Epidural anesthesia blocks sympathetic drive and may decrease maternal blood pressure, resulting in a transient reduction in placental blood flow.&nbsp; This typically leads to fetal bradycardia and/or late decelerations.</p><p><strong>(Choice C)</strong>&nbsp; Magnesium sulfate prevents maternal seizures (eclampsia) in patients with preeclampsia with severe features, as in this patient.&nbsp; Although magnesium sulfate administration can cause decreased fetal heart rate <a href=\"2157\">variability</a> due to CNS depression, the effect is typically transient and would not explain this patient&#39;s fever, maternal tachycardia, or fetal tachycardia.&nbsp; Maternal infection, as in this patient, can be a cause of minimal variability due to fetal hypoxia.</p><p><strong>(Choice E)</strong>&nbsp; Uterine tachysystole (&gt;5 contractions in 10 min) may be associated with <a href=\"1820\">late fetal decelerations</a> because there is a transient decrease in placental perfusion during contractions and inadequate recovery time between contractions.&nbsp; This patient has had only 4 contractions in 10 minutes.</p><p><strong>Educational objective:</strong><br>Fetal tachycardia is defined as a fetal heart rate baseline &gt;160/min and is commonly associated with maternal fever due to intraamniotic infection (chorioamnionitis).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 22374,
            "topic": "Fetal heart tracing",
            "titleId": 22374,
            "title": "Fetal heart tracing",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Congenital hypothyroidism",
                    "choiceNumber": 1,
                    "correctTaken": 1313,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Epidural anesthesia",
                    "choiceNumber": 2,
                    "correctTaken": 1205,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Magnesium sulfate",
                    "choiceNumber": 3,
                    "correctTaken": 1402,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maternal fever",
                    "choiceNumber": 4,
                    "correctTaken": 10285,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Uterine tachysystole",
                    "choiceNumber": 5,
                    "correctTaken": 1794,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "34211129",
                    "mediaDataId": 0,
                    "title": "Chorioamnionitis and neonatal outcomes.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/34211129",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27386764",
                    "mediaDataId": 0,
                    "title": "Fever and pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27386764",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 103,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 15999,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 3337,
            "questionIndex": 3337,
            "questionText": "<p>A 20-year-old woman, gravida 2 para 2, is evaluated in the postpartum unit 8 hours after vaginal delivery.&nbsp; She is experiencing fatigue, perineal discomfort, and bloody vaginal discharge.&nbsp; The patient has voided 3 times since delivery.&nbsp; She was admitted to the hospital for rupture of membranes at 40 weeks gestation and, after a prolonged induction, had an uncomplicated vaginal delivery under epidural anesthesia with a second-degree laceration that was immediately repaired.&nbsp; The placenta delivered spontaneously, after which the patient had an episode of rigors and chills for 30 minutes that has not recurred.&nbsp; Estimated delivery-related blood loss was 300 mL; the patient received an oxytocin infusion for 4 hours after delivery.&nbsp; Temperature is 37.9 C (100.2 F), blood pressure is 120/80 mm Hg, and pulse is 76/min.&nbsp; Pelvic examination shows an intact perineal repair with minimal bloody discharge and small blood clots on the perineal pad.&nbsp; The uterine fundus is firm, nontender, and palpable at the umbilicus.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t50313\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Postpartum period</strong></p></td></tr><tr><td><p align=\"center\"><strong>Normal<br />findings</strong></p></td><td><ul><li>Transient rigors/chills</li><li>Peripheral edema</li><li>Lochia rubra</li><li>Uterine contraction &amp; involution</li><li>Breast engorgement</li></ul></td></tr><tr><td><p align=\"center\"><strong>Routine<br />care</strong></p></td><td><ul><li>Rooming-in/lactation support</li><li>Serial examination for uterine atony/bleeding</li><li>Perineal care</li><li>Voiding trial</li><li>Pain management</li></ul></td></tr></tbody></table></div><p>The <strong>immediate postpartum period</strong> (ie, hours to days) is marked by physiologic changes that begin immediately after placental delivery:</p><ul><li><strong>Increased oxytocin levels</strong> (endogenous and administered) cause <strong>uterine contraction</strong>, which compresses placental bed vessels and protects against postpartum hemorrhage.&nbsp; As the uterus involutes, it rapidly decreases in size, becoming firm and palpable 1-2 cm above or below the umbilicus.&nbsp; Involution also generates subsequent <strong>lochia</strong> (shedding of the uterine decidua and blood), which initially appears bloody with small clots and can continue for several weeks.</li><li><strong>Increased prolactin levels</strong> stimulate breast milk excretion and milk letdown over the course of hours to days.&nbsp; Infant suckling further increases maternal prolactin and oxytocin levels (ie, positive feedback).</li><li><strong>Decreased estrogen and progesterone levels</strong> may cause postpartum <strong>chills and shivering</strong>, with subsequent mild hyperthermia/low-grade fever in the first 24 hours after delivery.</li></ul><p>This patient&#39;s postpartum course is normal (eg, shivering, firm contracted uterus, normal lochia).&nbsp; Therefore, only <strong>routine postpartum care</strong> with pain management, perineal care, and lactation support is indicated.</p><p><strong>(Choices A, C, and E)</strong>&nbsp; Postpartum fever is a temperature &#8805;38.0 C (100.4 F), exclusive of the first 24 hours after delivery.&nbsp; This patient&#39;s temperature of 37.9 C (100.2 F) at 8 hours postpartum is most consistent with mild hyperthermia from normal postpartum shivering.&nbsp; She has no signs of infection (eg, nontender uterus, intact perineal laceration repair, normal voiding) or retained placenta (eg, firm uterus, normal lochia) and therefore does not require broad-spectrum antibiotics, pelvic ultrasound, or urinalysis/urine culture.</p><p><strong>(Choice B)</strong>&nbsp; Oxytocin treats postpartum uterine atony, which typically presents as a boggy, or poorly contracted, uterus and postpartum hemorrhage.&nbsp; This patient&#39;s uterus is well contracted, and her minimal bloody discharge is consistent with normal lochia.</p><p><strong>Educational objective:</strong><br>In the immediate postpartum period, physiologic changes include uterine contraction, lochia, breast milk excretion and milk letdown, and chills and shivering causing hyperthermia or low-grade fever. These changes are hormone-mediated (eg, increased oxytocin/prolactin levels, decreased estrogen/progesterone levels).&nbsp; Patients with these normal findings are managed with routine postpartum care.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14027,
            "topic": "Normal postpartum",
            "titleId": 14027,
            "title": "Normal postpartum",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Broad-spectrum antibiotics",
                    "choiceNumber": 1,
                    "correctTaken": 3726,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oxytocin infusion",
                    "choiceNumber": 2,
                    "correctTaken": 211,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic ultrasound",
                    "choiceNumber": 3,
                    "correctTaken": 1431,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Routine postpartum care only",
                    "choiceNumber": 4,
                    "correctTaken": 10395,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urinalysis and urine culture",
                    "choiceNumber": 5,
                    "correctTaken": 1040,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18839822",
                    "mediaDataId": 0,
                    "title": "Shaking rigors in parturients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18839822",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23101487",
                    "mediaDataId": 0,
                    "title": "Lochia patterns among normal women: a systematic review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23101487",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21463537",
                    "mediaDataId": 0,
                    "title": "Postpartum haemorrhage: prevention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21463537",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 257,
            "othersAvgTimeSpent": 75,
            "notes": null,
            "peopleTaken": 16803,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 14290,
            "questionIndex": 15698,
            "questionText": "<p>A 24-year-old woman, gravida 1 para 0, at 26 weeks gestation comes to the office due to increased urinary frequency and back pain.&nbsp; For the past 2 weeks, the patient has had to urinate almost hourly during the day and has awakened multiple times each night to void.&nbsp; She has also developed back pain and occasionally has a sharp, pulling pain in the right groin.&nbsp; The patient has no nausea, vomiting, dysuria, or hematuria.&nbsp; She has had no vaginal bleeding, leakage of fluid, or contractions.&nbsp; Fetal movement is normal.&nbsp; The patient has had recurrent nephrolithiasis outside of pregnancy.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 130/80 mm Hg, and pulse is 72/min.&nbsp; There is tenderness to palpation throughout the lower back and along the paravertebral muscles.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">0.6 mg/dL</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\" height=\"15\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Urinalysis</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Specific gravity</td><td style=\"vertical-align:middle;\">1.001</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Protein</td><td style=\"vertical-align:middle;\">trace</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Leukocyte esterase</td><td style=\"vertical-align:middle;\">negative</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;White blood cells</td><td style=\"vertical-align:middle;\">1-2/hpf</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Red blood cells</td><td style=\"vertical-align:middle;\">negative</td></tr></tbody></table><p>Renal and pelvic ultrasound of the mother reveals bilateral enlargement of the kidneys.&nbsp; The right kidney is larger than the left; there is dilation of the renal pelvis and proximal ureter on both sides.&nbsp; Which of the following is the best next step in management of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"23630\" src=\"https://www.uworld.com/media/L50001.jpg\" ></p><p>This patient has nonspecific, common symptoms of pregnancy including urinary frequency, nocturia, back pain, and round ligament pain (ie, sharp groin pain).&nbsp; Although her examination is benign and her laboratory results are normal for pregnancy, a renal ultrasound can be performed due to her recurrent nephrolithiasis.&nbsp; The renal ultrasound findings of bilateral kidney enlargement and bilateral dilation of the renal pelvises and proximal ureters are consistent with <strong>physiologic hydronephrosis of pregnancy</strong>.</p><p>During pregnancy, kidney enlargement occurs because there is an increase in maternal blood volume that requires increased renal filtration, resulting in greater renal vasculature and interstitial tissue.&nbsp; Hydronephrosis begins during the first trimester as high progesterone levels cause ureteral dilation and decreased peristalsis.&nbsp; Hydronephrosis becomes more pronounced in the second and third trimesters as uterine enlargement compresses the ureters at the pelvic brim, which results in <strong>dilation of the proximal ureters</strong> and <strong>bilateral hydronephrosis</strong>.&nbsp; Right hydronephrosis is often more pronounced due to dextrorotation of the uterus, which causes increased compression of the right ureter.&nbsp; Unlike pathologic hydronephrosis (eg, secondary to obstruction or infection), physiologic hydronephrosis of pregnancy requires <strong>no additional management</strong>.</p><p><strong>(Choices A and C)</strong>&nbsp; Ureteral stents and nephrostomy tubes are inserted when the etiology of hydronephrosis is ureteral blockage (eg, nephrolithiasis).&nbsp; Obstruction usually presents with microscopic hematuria and unilateral imaging findings (eg, visible stone, unilateral hydronephrosis).&nbsp; This patient&#39;s urinalysis is negative for blood, and she has bilateral findings on ultrasound.</p><p><strong>(Choice B)</strong>&nbsp; Disorders of bladder outlet obstruction are treated with Foley catheter placement.&nbsp; In contrast to this patient, those with bladder outlet obstruction have decreased urination (rather than frequency) and have both distal and proximal ureteral dilation.</p><p><strong>(Choice E)</strong>&nbsp; Urodynamic testing is performed to evaluate mixed urinary incontinence (eg, urgency and stress) outside of pregnancy.&nbsp; Urinary frequency and nocturia are normal in pregnancy due to bladder compression by the uterus and nighttime shifting of edema back into circulation.</p><p><strong>Educational objective:</strong><br>Hydronephrosis in pregnancy occurs due to ureteral compression from uterine enlargement and decreased ureteral peristalsis due to increased progesterone.&nbsp; Ultrasound findings include bilateral renal enlargement (right &gt; left) with dilated renal pelvises and proximal ureters.&nbsp; Physiologic hydronephrosis of pregnancy requires no additional management.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 23488,
            "topic": "Urinary tract obstruction",
            "titleId": 23488,
            "title": "Urinary tract obstruction",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cystoscopy with ureteral stent insertion",
                    "choiceNumber": 1,
                    "correctTaken": 4680,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Foley catheter placement",
                    "choiceNumber": 2,
                    "correctTaken": 1755,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nephrostomy tube placement",
                    "choiceNumber": 3,
                    "correctTaken": 1923,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional management indicated",
                    "choiceNumber": 4,
                    "correctTaken": 6438,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Urodynamic testing",
                    "choiceNumber": 5,
                    "correctTaken": 1940,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "6849041",
                    "mediaDataId": 0,
                    "title": "Ultrasonic assessment of hydronephrosis of pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/6849041",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "3280355",
                    "mediaDataId": 0,
                    "title": "Hydronephrosis during pregnancy: a literature survey.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/3280355",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23928384",
                    "mediaDataId": 0,
                    "title": "Renal physiology of pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23928384",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 151,
            "othersAvgTimeSpent": 83,
            "notes": null,
            "peopleTaken": 16736,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 38,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 4050,
            "questionIndex": 4050,
            "questionText": "<p>A 36-year-old woman, gravida 2 para 1, at 32 weeks gestation comes to the office with dull, low back pain radiating bilaterally to the buttocks and posterior thighs.&nbsp; The pain is minimal in the morning but increases with activity and at the end of the day.&nbsp; She also has ankle edema and numbness in her feet at the end of the day.&nbsp; The patient has urinary frequency and nocturia but no hematuria or dysuria.&nbsp; She had no back pain in her first pregnancy.&nbsp; During that delivery, the patient received epidural anesthesia and had a post&ndash;lumbar puncture headache after removal that was treated with an epidural blood patch.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 120/80 mm Hg, and pulse is 90/min.&nbsp; She has gained 20 kg (44.1 lb) during this pregnancy.&nbsp; On physical examination, the patient ambulates with a wide, waddling gait.&nbsp; Walking forward or backward causes no change in pain level.&nbsp; There is no spinal or paravertebral tenderness.&nbsp; Deep tendon reflexes are 2+.&nbsp; The abdomen is soft, and the cervix is long, closed, and posterior.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T31879\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Low back pain during pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Enlarged uterus &#8594; exaggerated lordosis</li><li>Joint/ligament laxity from &#8593; progesterone/relaxin</li><li>Weak abdominal muscles &#8594; decreased lumbar support</li></ul></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Excessive weight gain</li><li>Chronic back pain&nbsp;</li><li>Back pain in prior pregnancy</li><li>Multiparity</li></ul></td></tr><tr><td><p align=\"center\"><strong>Imaging</strong></p></td><td><ul><li>Not indicated</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Behavioral modifications</li><li>Heating pads</li><li>Analgesics&nbsp;</li></ul></td></tr></tbody></table></div><p><strong>Low back pain</strong> and waddling gait are common in <strong>pregnancy</strong>, especially in the third trimester because uterine enlargement causes exaggerated lordosis and postural changes.&nbsp; Other contributing factors include weakened abdominal muscles and increased joint/ligament laxity.&nbsp; Risk factors include multiparity and excessive weight gain, as in this patient.&nbsp; Prior neuraxial anesthesia does not increase the risk for long-term back pain.</p><p>Back pain during pregnancy typically manifests as <strong>mechanical back pain</strong> (eg, position-dependent, achy, worsened with activity, relieved with rest).&nbsp; In contrast, concerning nonmechanical causes of back pain (eg, preterm labor, pyelonephritis, spinal malignancy) may present with fever, neurologic deficits (eg, bowel or bladder incontinence), and constant, nonpositional, nocturnal back pain.</p><p>This patient has <strong>no associated neurologic deficits</strong>.&nbsp; Her back pain is bilateral without radiation below the knee, making lumbosacral radiculopathy (sciatica) unlikely.&nbsp; The numbness in her feet, which is present only at the end of the day, is likely related to physiologic ankle edema.&nbsp; Patients with no concerning findings, such as this one, should receive <strong>reassurance</strong> that the back pain is normal and will resolve postpartum.&nbsp; <strong>Conservative management</strong>, such as behavioral modifications (eg, wearing supportive shoes, using a firm mattress) and exercise, is recommended.&nbsp; Heating pads and massage are also beneficial.</p><p><strong>(Choice A)</strong>&nbsp; Epidural corticosteroid injections can provide short-term relief for chronic radicular pain from lumbar disc herniation (ie, unilateral pain radiating below the knee along the sciatic nerve).&nbsp; However, this patient&#39;s pain is bilateral and does not radiate below the knee, making this diagnosis unlikely.&nbsp; Epidural injections are not recommended for mechanical back pain.</p><p><strong>(Choice B)</strong>&nbsp; MRI is the preferred imaging modality for pregnant women with back pain but is usually needed only when there are associated neurologic deficits, features of infection (eg, fever, focal spinal tenderness), or malignancy (eg, unexpected weight loss).&nbsp; Minor pregnancy-related symptoms (eg, urinary frequency, edema) do not require imaging.</p><p><strong>(Choice D)</strong>&nbsp; Strict bed rest is rarely recommended in pregnancy due to the increased risk for thromboembolism, bone loss, and physical deconditioning, which can exacerbate back pain.</p><p><strong>(Choice E)</strong>&nbsp; Nonsteroidal anti-inflammatory drugs (eg, ibuprofen, naproxen) are avoided in the first and third trimesters due to risks for renal teratogenicity and premature closure of the ductus arteriosus.</p><p><strong>Educational objective:</strong><br>Low back pain is common in the third trimester due to postural changes, weakened abdominal muscles, and joint/ligament laxity.&nbsp; Patients with no concerning findings or neurologic deficits should receive reassurance and conservative management (eg, exercise, heating pads, massage).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14160,
            "topic": "Normal pregnancy",
            "titleId": 14160,
            "title": "Normal pregnancy",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Corticosteroid injection",
                    "choiceNumber": 1,
                    "correctTaken": 292,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the spine",
                    "choiceNumber": 2,
                    "correctTaken": 1920,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and conservative management",
                    "choiceNumber": 3,
                    "correctTaken": 12560,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Strict bed rest",
                    "choiceNumber": 4,
                    "correctTaken": 242,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trial of a nonsteroidal anti-inflammatory agent",
                    "choiceNumber": 5,
                    "correctTaken": 1718,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26422811",
                    "mediaDataId": 0,
                    "title": "Interventions for preventing and treating low-back and pelvic pain during pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26422811",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27190453",
                    "mediaDataId": 0,
                    "title": "Impact of pregnancy on back pain and body posture in women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27190453",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 114,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 16732,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 2406,
            "questionIndex": 2406,
            "questionText": "<p>A 24-year-old woman, gravida 2 para 1, at 37 weeks gestation comes to the office requesting induction of labor.&nbsp; The patient says that the last few weeks of pregnancy have been &#x22;very uncomfortable&#x22; due to exhaustion and shortness of breath while walking.&nbsp; She has bilateral foot and ankle swelling and is unable to fit into her shoes.&nbsp; The patient has difficulty sleeping at night due to the baby&#39;s frequent movement and due to bilateral crampy pain in her calves; the pain is relieved by massage and stretching.&nbsp; Review of systems is negative for contractions, vaginal bleeding, and loss of fluid.&nbsp; Temperature is 36.8 C (98.2 F), blood pressure is 120/70 mm Hg, pulse is 105/min, and respiratory rate is 18/min.&nbsp; Physical examination shows symmetric, bilateral pitting edema of the calves, ankles, and feet.&nbsp; Cardiac auscultation shows a 2/6 systolic ejection murmur.&nbsp; The lungs are clear to auscultation.&nbsp; Fundal height is 38 cm.&nbsp; Urinalysis shows trace protein.&nbsp; Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t39295\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Maternal cardiopulmonary adaptations to pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Maternal<br />adaptations</strong></p></td><td><ul><li>Cardiac<ul style=\"list-style-type:circle;\"><li>&uarr; Cardiac output</li><li>&uarr; Plasma volume</li><li>&darr; Systemic vascular resistance</li></ul></li><li>Respiratory<ul style=\"list-style-type:circle;\"><li>&uarr; Tidal volume</li><li>&darr; Functional residual capacity<br />(elevation of diaphragm)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />manifestations</strong></p></td><td><ul><li>Peripheral edema</li><li>&darr; Blood pressure</li><li>&uarr; Heart rate</li><li>Systolic ejection murmur</li><li>Dyspnea</li></ul></td></tr></tbody></table></div><p><strong>Physiologic changes of pregnancy</strong> often lead to expected discomforts, especially during the third trimester.</p><ul><li><p>Hemodynamic changes include increases in cardiac output and plasma volume and decreases in systemic vascular resistance and blood pressure.&nbsp; The increased cardiac output is accomplished by increased stroke volume in early pregnancy and by increased heart rate in late pregnancy.&nbsp; Due to significant volume expansion and increased cardiac output, a <strong>systolic ejection, or flow, murmur</strong> is heard on examination.&nbsp; Additionally, volume expansion causes mild <strong>dependent</strong> (ie, lower-extremity) <strong>peripheral edema</strong>.</p></li><li><p>Respiratory adaptations lead to <strong>dyspnea</strong>.&nbsp; Progesterone increases minute ventilation through an increase in tidal volume, although the respiratory rate remains unchanged.&nbsp; In addition, the enlarging uterus elevates the diaphragm, resulting in decreased functional residual capacity.</p></li><li><p>Nocturnal leg cramps are also common, likely due to a buildup of lactic and pyruvic acid secondary to increased metabolic demand, leading to involuntary muscular contractions.</p></li></ul><p><strong>Reassurance</strong> and routine prenatal care are indicated for this patient, who is experiencing normal manifestations of physiologic adaptations to pregnancy.&nbsp; Although she is full-term, a 37-week gestation induction is contraindicated without a medical reason (eg, preeclampsia) because of the risks (eg, transient tachypnea of the newborn, hypoglycemia) associated with an early-term newborn <strong>(Choice E)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; A 24-hour urine collection for total protein is part of the evaluation for preeclampsia, the cardinal features of which include hypertension (blood pressure &#8805;140/90 mm Hg during pregnancy), edema, and pathologic proteinuria.&nbsp; This normotensive patient has trace protein on urinalysis, a normal finding in pregnancy due to increased urinary protein excretion.&nbsp; Without hypertension, preeclampsia is unlikely.</p><p><strong>(Choice B)</strong>&nbsp; CT pulmonary angiography is used to diagnose a pulmonary embolism (PE).&nbsp; Although pregnancy increases PE risk, the absence of tachycardia, tachypnea, pleuritic chest pain, cough, and calf tenderness makes evaluation for PE unnecessary.&nbsp; This patient&#39;s heart rate is normal in the third trimester.</p><p><strong>(Choice C)</strong>&nbsp; Doppler ultrasound is used to evaluate for deep vein thrombosis, which typically presents with unilateral calf or thigh pain that cannot be relieved by massage, as well as swelling and redness.&nbsp; This patient&#39;s calf pain is bilateral and relieved by massage.</p><p><strong>(Choice D)</strong>&nbsp; An echocardiogram would be indicated to evaluate for peripartum cardiomyopathy, which may cause peripheral edema and dyspnea.&nbsp; However, the absence of cough, crackles, hemoptysis, and a holosystolic mitral regurgitation murmur makes further workup unnecessary.</p><p><strong>Educational objective:</strong><br>Maternal adaptations to pregnancy include increases in cardiac output, plasma volume, and tidal volume.&nbsp; Systolic ejection murmur, peripheral edema, and dyspnea are common but benign symptoms that result from these changes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 14160,
            "topic": "Normal pregnancy",
            "titleId": 14160,
            "title": "Normal pregnancy",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "6",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "24-hour urine collection for total protein",
                    "choiceNumber": 1,
                    "correctTaken": 1009,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT pulmonary angiography",
                    "choiceNumber": 2,
                    "correctTaken": 243,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Doppler sonography of the lower extremities",
                    "choiceNumber": 3,
                    "correctTaken": 1075,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Echocardiogram",
                    "choiceNumber": 4,
                    "correctTaken": 4144,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immediate induction of labor",
                    "choiceNumber": 5,
                    "correctTaken": 1225,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and routine follow-up",
                    "choiceNumber": 6,
                    "correctTaken": 8955,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22840789",
                    "mediaDataId": 0,
                    "title": "Physiologic adaptations to pregnancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22840789",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 16651,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 9822,
            "questionIndex": 10441,
            "questionText": "<p>A 40-year-old woman, gravida 2 para 1, comes to the office for her initial prenatal visit.&nbsp; She is at 10 weeks gestation based on her last menstrual period.&nbsp; The patient has no concerns today and feels well.&nbsp; She had light vaginal bleeding 6 weeks ago, but none since then.&nbsp; Her first pregnancy ended in a term vaginal delivery.&nbsp; The patient has no chronic medical conditions or prior surgeries and takes no daily medications.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Blood pressure is 118/64 mm Hg and pulse is 82/min.&nbsp; BMI is 22 kg/m&sup2;.&nbsp; Physical examination is unremarkable.&nbsp; Ultrasound reveals an intrauterine fetal pole at 10 weeks gestation with fetal heart rate at 160/min.&nbsp; In addition to routine prenatal laboratory testing, which of the following tests is recommended for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36752\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Cell-free fetal DNA testing </strong></p></td></tr><tr><td><p align=\"center\"><strong>Indications </strong></p></td><td><ul><li>Maternal age &ge;35 &nbsp;</li><li>Abnormal maternal serum screening test</li><li>Sonographic findings associated with fetal aneuploidy</li><li>Prior pregnancy with fetal aneuploidy</li><li>Parental-balanced robertsonian translocation</li></ul></td></tr><tr><td><p align=\"center\"><strong>Applications </strong></p></td><td><ul><li>Screening for trisomy 21, 18, 13 &amp; sex chromosome aneuploidies</li><li>Fetal sex determination</li></ul></td></tr></tbody></table></div><p>The initial prenatal visit uses a combination of maternal history and <strong>prenatal testing</strong> to identify patients at risk for obstetric complications.&nbsp; Prenatal testing can be routine (eg, HIV screen, maternal blood typing) or <strong>risk based</strong>.</p><p>Women <strong>age &#8805;35</strong> (ie, advanced maternal age) are at increased risk of <strong>fetal aneuploidy</strong> and are offered <strong>cell-free fetal DNA testing</strong> (cffDNA) of maternal plasma.&nbsp; Other indications include abnormal maternal serum screening test results (eg, quadruple screen) or an abnormal ultrasound.&nbsp; Noninvasive cffDNA testing can be performed at &#8805;10 weeks gestation and has a high sensitivity and specificity for detecting trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), and trisomy 13 (Patau syndrome).&nbsp; It can also identify the fetal sex and some sex chromosome disorders.</p><p>Normal results are reassuring and typically require no additional evaluation.&nbsp; Abnormal results are confirmed by fetal karyotyping via first-trimester chorionic villus sampling or second-trimester amniocentesis.</p><p><strong>(Choice B)</strong>&nbsp; Cytomegalovirus antibody testing is indicated in patients with a suspected congenital infection (eg, fetal growth restriction, periventricular calcifications); however, routine screening is not performed.</p><p><strong>(Choice C)</strong>&nbsp; Screening for inherited thrombophilias (eg, antithrombin deficiency) is not recommended in patients without risk factors such as family history or prior venous thromboembolism.</p><p><strong>(Choice D)</strong>&nbsp; Quantitative &#946;-hCG levels are indicated in patients with a pregnancy of unknown location because abnormal levels may indicate an ectopic pregnancy; &#946;-hCG levels have no clinical value once an intrauterine pregnancy is confirmed on ultrasound, as in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Although prenatal screening for <em>Chlamydia trachomatis</em> and <em>Neisseria gonorrhoeae</em> is routine, <em>Trichomonas vaginalis</em> nucleic acid amplification testing is indicated only in symptomatic patients or those with risk factors (eg, HIV).</p><p><strong>Educational objective:</strong><br>Cell-free fetal DNA testing is a noninvasive and highly sensitive and specific screening test for fetal aneuploidy.&nbsp; It is performed at &#8805;10 weeks gestation, and abnormal results are confirmed by chorionic villus sampling or amniocentesis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 19194,
            "topic": "Prenatal Care",
            "titleId": 19194,
            "title": "Prenatal Care",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cell-free fetal DNA test",
                    "choiceNumber": 1,
                    "correctTaken": 10040,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cytomegalovirus antibody test",
                    "choiceNumber": 2,
                    "correctTaken": 1502,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma antithrombin activity level",
                    "choiceNumber": 3,
                    "correctTaken": 684,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quantitative &#946;-hCG level",
                    "choiceNumber": 4,
                    "correctTaken": 3062,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<em>Trichomonas vaginalis</em> nucleic acid amplification test",
                    "choiceNumber": 5,
                    "correctTaken": 1517,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26287791",
                    "mediaDataId": 0,
                    "title": "ACOG committee opinion no. 640: cell-free DNA screening for fetal aneuploidy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26287791",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24807333",
                    "mediaDataId": 0,
                    "title": "Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24807333",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 115,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16805,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 4530,
            "questionIndex": 4530,
            "questionText": "<p>A 29-year-old woman, gravida 2 para 1, comes to the office at 10 weeks gestation for her first prenatal visit.&nbsp; The patient feels well and has had no vaginal bleeding or pelvic pain.&nbsp; Her first pregnancy ended in an uncomplicated vaginal delivery, but she required penicillin during labor for group B <em>Streptococcus</em> colonization.&nbsp; The patient has no chronic medical conditions and takes no daily medications.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; She has been in a monogamous relationship with her husband since they married 5 years ago.&nbsp; They live in a house built in 1983.&nbsp; Vital signs are normal.&nbsp; BMI is 24 kg/m&sup2;.&nbsp; Uterine size is at 10 weeks gestation, and fetal heart tones are 162/min.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Which of the following screening tests is indicated at this visit?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34101\"><table class=\"table-default-style table-header-footer-style\" style=\"width:504px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Syphilis in pregnancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Screening </strong></p></td><td><ul><li>Universal at 1st prenatal visit</li><li>3rd trimester &amp; delivery (if high risk)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Serologic tests </strong></p></td><td><ul><li>Nontreponemal (RPR, VDRL)</li><li>Treponemal (FTA-ABS)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment </strong></p></td><td><ul><li>Intramuscular penicillin G benzathine</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pregnancy effects </strong></p></td><td><ul><li>Intrauterine fetal demise</li><li>Preterm labor</li></ul></td></tr><tr><td><p align=\"center\"><strong>Fetal effects </strong></p></td><td><ul><li>Hepatic (hepatomegaly, jaundice)</li><li>Hematologic (hemolytic anemia, <strong>&darr;</strong> platelets)</li><li>Musculoskeletal (long bone abnormalities)</li><li>Failure to thrive</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>FTA-ABS</strong> = fluorescent treponemal antibody-absorption; <strong>RPR</strong> = rapid plasma reagin<span style=\"display:none\">&nbsp;</span>.</p></td></tr></tbody></table></div><p>Assessing maternal health, infections, and exposures is an important part of the <strong>first prenatal visit</strong>.&nbsp; As part of this assessment, a <a href=\"5248\">standard set</a> of <strong>routine screening tests</strong> is recommended for every pregnant patient.&nbsp; Identifying <strong>sexually transmitted infections</strong> (STIs) is particularly important because many maternal-fetal transmissions are serious yet preventable with proper intervention.&nbsp; Therefore, universal screening for HIV, hepatitis B virus, and syphilis is required at the initial prenatal visit.&nbsp; High-risk patients (eg, prior STI, age &lt;25) are also screened for <em>Chlamydia trachomatis</em>.</p><p><strong>Syphilis</strong> can result in transplacental transmission with devastating <strong>obstetric</strong> (eg, preterm labor) and <strong>fetal</strong> (eg, intrauterine fetal demise) <strong>complications</strong>.&nbsp; At-risk patients are identified by screening with <strong>nontreponemal</strong> (eg, <strong>rapid plasma reagin</strong>) or <strong>treponemal</strong> (eg, fluorescent treponemal antibody absorption) <strong>serology</strong>.&nbsp; Either type may be used, but positive results require confirmation with a test from the alternate category because false-positive results are common.&nbsp; Treatment for syphilis is with <strong>intramuscular benzathine penicillin G</strong>.&nbsp; Pregnant women with penicillin allergy are a unique population; they typically undergo <strong>penicillin desensitization</strong> for syphilis treatment (due to the superior efficacy of penicillin and severity of syphilis-related fetal complications).</p><p><strong>(Choice A)</strong>&nbsp; An early 1-hour glucose challenge test may be indicated in patients with diabetes risk factors (eg, obesity, prior gestational diabetes mellitus).&nbsp; This patient has no risk factors and can undergo routine screening for gestational diabetes mellitus at 24-28 weeks gestation.</p><p><strong>(Choice B)</strong>&nbsp; This patient received intrapartum penicillin prophylaxis during her last delivery to prevent vertical transmission of group B <em>Streptococcus</em> (GBS).&nbsp; Because GBS is a transient colonizer of the maternal genitourinary tract, screening by rectovaginal culture should occur close to the anticipated delivery date (ie, 36-38 weeks gestation), not at 10 weeks gestation.</p><p><strong>(Choice C)</strong>&nbsp; Routine testing for herpes simplex virus (HSV) antibodies is not recommended due to low specificity and high false-positive rates in asymptomatic patients.&nbsp; Symptomatic patients (eg, new, painful, vesicular genital ulcers) require HSV testing, typically with PCR.</p><p><strong>(Choice E)</strong>&nbsp; Folic acid deficiency in pregnancy is associated with fetal neural tube defects.&nbsp; Although supplementation is recommended, folate levels are not commonly tested.</p><p><strong>(Choice F)</strong>&nbsp; Patients at risk for significant lead exposure (eg, living in a home built before 1978) require measurement of serum lead levels.</p><p><strong>Educational objective:</strong><br>Universal screening for syphilis is required at the first prenatal visit to identify patients at risk for transplacental transmission and associated obstetric and fetal complications.&nbsp; Syphilis is treated with intramuscular benzathine penicillin G.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 214,
            "system": "Pregnancy, Childbirth & Puerperium",
            "topicId": 15559,
            "topic": "Syphilis",
            "titleId": 15559,
            "title": "Syphilis",
            "topicAttributeId": 330636,
            "topicAttribute": "Normal pregnancy, childbirth, and puerperium",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "1-hr glucose challenge test",
                    "choiceNumber": 1,
                    "correctTaken": 310,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Group B <em>Streptococcus</em> rectovaginal culture",
                    "choiceNumber": 2,
                    "correctTaken": 344,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Herpes simplex virus antibody testing",
                    "choiceNumber": 3,
                    "correctTaken": 202,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid plasma reagin test",
                    "choiceNumber": 4,
                    "correctTaken": 3180,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum folate level measurement",
                    "choiceNumber": 5,
                    "correctTaken": 347,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum lead level measurement",
                    "choiceNumber": 6,
                    "correctTaken": 761,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27929270",
                    "mediaDataId": 0,
                    "title": "Sexually transmitted infections: recommendations from the U.S. Preventive Services Task Force.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27929270",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23476094",
                    "mediaDataId": 0,
                    "title": "Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23476094",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 71,
            "notes": null,
            "peopleTaken": 5144,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 203,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 4,
            "name": "CUSTOM"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}